SEARCH
Search Details
Last Updated :2024/11/23
Department of Sports Science／Department of Health and Exercise Science
Professor
Research activity information
■ Paper
- Differences in the effects of exercise on blood pressure depending on the physical condition of the subject and the type of exercise: a systematic review and meta-analysis.
Yasunori Suematsu; Hidetaka Morita; Makiko Abe; Yoshinari Uehara; Rie Koyoshi; Kanta Fujimi; Akihito Ideishi; Kohei Takata; Yuta Kato; Tetsuo Hirata; Eiji Yahiro; Natsumi Morito; Ken Kitajima; Yuiko Yano; Atsushi Satoh; Chikara Yoshimura; Shintaro Ishida; Shota Okutsu; Koji Takahashi; Yukiko Shinohara; Takashi Sakaguchi; Shiori Katsuki; Kazuhiro Tada; Takako Fujii; Shunsuke Funakoshi; Yaopeng Hu; Tomonori Satoh; Hirofumi Ohnishi; Keisuke Okamura; Hiroyuki Mizuno; Kimika Arakawa; Kei Asayama; Toshio Ohtsubo; Tomoaki Ishigami; Shigeru Shibata; Takayuki Fujita; Masanori Munakata; Mitsuru Ohishi; Atsuhiro Ichihara; Tomohiro Katsuya; Masashi Mukoyama; Hiromi Rakugi; Koichi Node; Hisatomi Arima; Shin-Ichiro Miura
Hypertension research : official journal of the Japanese Society of Hypertension, 01 Nov. 2024 - Greater energy surplus promotes body protein accretion in healthy young men: A randomized clinical trial.
Yoichi Hatamoto; Yukiya Tanoue; Ryoichi Tagawa; Jun Yasukata; Keisuke Shiose; Yujiro Kose; Daiki Watanabe; Shigeho Tanaka; Kong Y Chen; Naoyuki Ebine; Keisuke Ueda; Yoshinari Uehara; Yasuki Higaki; Chiaki Sanbongi; Kentaro Kawanaka
Clinical nutrition (Edinburgh, Scotland), 30 Sep. 2024, 43(12):48 - 60 - 脂質・脂溶性ビタミン吸収障害のないMTTP複合ヘテロ接合体の1例
佐々木 慧; 多田 隼人; 小松 知広; 寺田 尚人; 遠藤 康弘; 池脇 克則; 上原 吉就
日本動脈硬化学会総会プログラム・抄録集, Jun. 2024, 56回:172 - 172 - A New Case of Abetalipoproteinemia Caused by Novel Compound Heterozygote Mutations in the MTTP Gene without Fat or Vitamin Malabsorption.
Kei Sasaki; Hayato Tada; Tomohiro Komatsu; Hisato Terada; Yasuhiro Endo; Katsunori Ikewaki; Yoshinari Uehara
Journal of atherosclerosis and thrombosis, 14 May 2024, :in press, Refereed
Last - Reply to “letter to the editor: Measuring renal hemodynamics during exercise using Doppler ultrasound”
Shotaro Kawakami; Tetsuhiko Yasuno; Saki Kawakami; Ai Ito; Kanta Fujimi; Takuro Matsuda; Shihoko Nakashima; Kosuke Masutani; Yoshinari Uehara; Yasuki Higaki; Ryoma Michishita
Physiological Reports, Apr. 2024, 12(8):e16018, Refereed - Effects of high‐intensity intermittent exercise versus moderate‐intensity continuous exercise on renal hemodynamics assessed by ultrasound echo
Shotaro Kawakami; Tetsuhiko Yasuno; Saki Kawakami; Ai Ito; Kanta Fujimi; Takuro Matsuda; Shihoko Nakashima; Kosuke Masutani; Yoshinari Uehara; Yasuki Higaki; Ryoma Michishita
Physiological Reports, 23 Jan. 2024, 12(2):e15925, Refereed - Cuban policosanol improves high-density lipoprotein cholesterol efflux capacity in healthy Japanese subjects
Yoshinari Uehara; Tomohiro Komatsu; Kei Sasaki; Satomi Abe; Shihoko Nakashima; Taiki Yamamoto; Ji-Eun Kim; Kyung-Hyun Cho
Frontiers in Nutrition, 08 Jan. 2024, 10:1297008, Refereed
Lead - The effects of intermittent or continuous exercise on renal haemodynamics during moderate-intensity exercise
Shotaro Kawakami; Tetsuhiko Yasuno; Saki Kawakami; Ai Ito; Kanta Fujimi; Takuro Matsuda; Shihoko Nakashima; Kosuke Masutani; Yoshinari Uehara; Yasuki Higaki; Ryoma Michishita
medRxiv, Jan. 2024 - The neuronal nitric oxide synthase expression increases during satellite cell-derived primary myoblasts differentiation
Masaki Kusano; Kazuya Sakai; Yuki Tomiga; Ai Ito; Shihoko Nakashima; Yoshinari Uehara; Kentaro Kawanaka; Yasuo Kitajima; Yasuki Higaki
Cellular and Molecular Biology, 10 Dec. 2023, 69(13):128 - 133, Refereed - The differences in renal hemodynamic response following high-intensity exercise between younger and older males.
Shotaro Kawakami; Tetsuhiko Yasuno; Kazuko Kotoku; Saki Kawakami; Ai Ito; Kanta Fujimi; Takuro Matsuda; Shihoko Nakashima; Kosuke Masutani; Yoshinari Uehara; Yasuki Higaki; Ryoma Michishita
Clinical and experimental nephrology, Nov. 2023, 27(11):972 - 980, Refereed - 24-h glucose level and variability in response to carbohydrate overfeeding assessed using continuous glucose monitoring system are associated with daily carbohydrate intake
Keisuke Shiose; Rie Tomiga Takae; Yoichi Hatamoto; Yasuki Higaki; Yoshinari Uehara
Clinical Nutrition ESPEN, 29 Jun. 2023, 57:166 - 172, Refereed
Last - Protection of Liver Functions and Improvement of Kidney Functions by Twelve Weeks Consumption of Cuban Policosanol (Raydel®) with a Decrease of Glycated Hemoglobin and Blood Pressure from a Randomized, Placebo-Controlled, and Double-Blinded Study with Healthy and Middle-Aged Japanese Participants
Kyung-Hyun Cho; Ji-Eun Kim; Tomohiro Komatsu; Yoshinari Uehara
Life, 04 Jun. 2023, 13(6):1319 - 1319, Refereed
Last - HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
Hang Zhang; Tomohiro Komatsu; Shihoko Nakashima; Satomi Abe; Emi Kawachi; Satoshi Imaizumi; Keijiro Saku; Yoshinari Uehara
European Cardiology Review, 25 Apr. 2023, 18, Refereed - The Validity of Ultra-Short-Term Heart Rate Variability during Cycling Exercise
Tanoue Y, Nakashima S, Komatsu T, Kosugi M, Kawakami S, Kawakami S, Michishita R, Higaki Y, Uehara Y.
Sensors, 22 Mar. 2023, 23(6):3325 - 3325, Refereed
Last - Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese
Kyung-Hyun Cho; Hyo-Seon Nam; Seung-Hee Baek; Dae-Jin Kang; Hyejee Na; Tomohiro Komatsu; Yoshinari Uehara
International Journal of Molecular Sciences, 08 Mar. 2023, 24(6):5185 - 5185, Refereed
Last - Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
Tomohiro Komatsu; Satomi Abe; Shihoko Nakashima; Kei Sasaki; Yasuki Higaki; Keijiro Saku; Shin-ichiro Miura; Yoshinari Uehara
Biomolecules, 24 Jan. 2023, 13(2):228 - 238, Refereed
Last - Effects of Aquatic Exercise Training on Physical Performance and Mood States in Male Collegiate Soccer Players
Ryoma Michishita; Taijiro Hide; Shotaro Kawakami; Yuta Kanegawa; Kohei Takayanagi; Masahiro Inui; Yoshinari Uehara; Yasuki Higaki
Translational Journal of the American College of Sports Medicine, 2023, 8(1), Refereed - Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin–Cholesterol Acyltransferase Autoantibody
Tomohiro Komatsu; Yuka Katsurada; Kazuya Miyashita; Satomi Abe; Takafumi Nishida; Yasuhiro Endo; Manami Teramoto; Kei Sasaki; Junko Arakawa; Makoto Sasaki; Natsuko Suzuki; Koji kuwata; Toshihiko Imakiire; Takayuki Miyake; Masami Sakurada; Susumu Matsukuma; Tsutomu Hirano; Yoshinari Uehara; Katsunori Ikewaki
Journal of Atherosclerosis and Thrombosis, Nov. 2022, 29:in press, Refereed - 骨格筋を介した血糖コントロールに人工甘味料がおよぼす影響
山本泰暉; 上原吉就
BIO Clinica, 10 Sep. 2022, 37(10):925 - 929 - The moderate‐intensity continuous exercise maintains renal blood flow and does not impair the renal function
Shotaro Kawakami; Tetsuhiko Yasuno; Saki Kawakami; Ai Ito; Kanta Fujimi; Takuro Matsuda; Shihoko Nakashima; Kosuke Masutani; Yoshinari Uehara; Yasuki Higaki; Ryoma Michishita
Physiological Reports, 04 Aug. 2022, 10(15):e15420, Refereed - Intermittent Exercise at Lactate Threshold Induces Lower Acute Stress than Its Continuous Counterpart in Middle-to-Older Aged Men.
Yamamoto, T; Tanoue, Y; Uehara, Y; Higaki, Y; Tanaka, H; Narazaki, K
Int. J. Environ. Res. Public Health, 19 Jun. 2022, 19(12):7503 - 7503, Refereed - 人工甘味料の糖代謝、骨格筋へおよぼす影響
山本泰暉; 上原吉就
Medical Science Digest, 25 Apr. 2022, 48(4 (633)):209 - 211 - Cognitive Improvement After Aerobic and Resistance Exercise Is Not Associated With Peripheral Biomarkers.
Ando S; Komiyama T; Tanoue Y; Sudo M; Costello JT; Uehara Y; Higaki Y
Front Behav Neurosci., 15 Mar. 2022, 16:853150 - 853150, Refereed - The ratio of heart rate to heart rate variability reflects sympathetic activity during incremental cycling exercise.
Tanoue Y; Komatsu T; Nakashima S; Matsuda T; Michishita R; Higaki Y; Uehara Y
Eur J Sport Sci., 21 Nov. 2021, 22(11):1 - 10, Refereed
Last - Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease
Shin-ichiro Miura; Yasunori Suematsu; Satoshi Imaizumi; Eiji Yahiro; Takashi Kuwano; Yoshinari Uehara; Keijiro Saku
CardioMetabolic Syndrome Journal, Sep. 2021, 1(2):135 - 144, Refereed - Short‐term running exercise alters DNA methylation patterns in neuronal nitric oxide synthase and brain‐derived neurotrophic factor genes in the mouse hippocampus and reduces anxiety‐like behaviors
Yuki Tomiga; Kazuya Sakai; Song‐Gyu Ra; Masaki Kusano; Ai Ito; Yoshinari Uehara; Hirokazu Takahashi; Kentaro Kawanaka; Hidenobu Soejima; Yasuki Higaki
The FASEB Journal, Aug. 2021, 35(8), Refereed - Short-term running exercise alters DNA methylation patterns in nNOS and BDNF genes in the mouse hippocampus and reduces anxiety-like behaviors
Tomiga Yuki; Sakai Kazuya; RA Song-Gyu; Kusano Masaki; Ito Ai; Uehara Yoshinari; Takahashi Hirokazu; Kawanaka Kentaro; Soejima Hidenobu; Higaki Yasuki
The FASEB journal, 29 Jul. 2021, Vol.35(No.8):e21767 - e21767, Refereed - The relationship between cognitive function and parasympathetic nerve activity after acute mild to moderate intensity exercise
Tanoue Y; Komiyama T; Tanaka T; Higaki Y; Uehara Y
J Phys Fitness Sports Med., 16 Jul. 2021, 10(4):181 - 189, Refereed
Last - High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients.
Komatsu T; Uehara Y
J Atheroscler Thromb, 01 Jul. 2021, 28:692 - 693, Refereed - The association between decreased kidney function and FIB4 index value, as indirect liver fibrosis, in middle-aged and older subjects.
Kazuko Kotoku; Ryoma Michishita; Takurou Matsuda; Shotaro Kawakami; Natsumi Morito; Yoshinari Uehara; Yasuki Higaki
Int J Environ Res Public Health, 29 Jun. 2021, 18(13):6980 - 6980, Refereed - DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
Deshimaru M; Kinoshita-Kawada M; Kubota K; Watanabe T; Tanaka Y; Hirano S; Ishidate F; Hiramoto M; Ishikawa M; Uehara Y; Okano H; Hirose S; Fujioka S; Iwasaki K; Yuasa-Kawada J; Mishima T; Tsuboi Y
Int J Mol Sci., 13 Apr. 2021, 22(8):3985, Refereed - Table tennis for patients with Parkinson’s disease: A single-center, prospective pilot study
Inoue K; Fujioka S; Nagaki K; Suenaga M; Kimura K; Yonekura Y; Yamaguchi Y; Kitano K; Imamura R; Uehara Y; Kikuchi H; Matsunaga Y; Tsuboi Y
Clin Park Relat Disord., 01 Apr. 2021, 4:100086 - 100086, Refereed - 心拍の揺らぎに含まれる自律神経成分を活用した新たな運動強度判定法の試み
田上友季也; 上原吉就
Bio Industry, 12 Mar. 2021, 38(3):82 - 86
Last - ミクロネシア連邦ポンペイ州における健康関連QOLについての報告 −ポンペイ州における「減量・肥満予防プログラム」導入事業（2016年度JICA草の根技術協力事業）より −
山本 泰暉; 栗山 緑; 水元 芳; 上原 吉就
福岡大学スポーツ科学研究, Mar. 2021, 51(2):7 - 16 - Validity of Bioimpedance Spectroscopy in the Assessment of Total Body Water and Body Composition in Wrestlers and Untrained Subjects
Shiose K; Kondo E; Takae R; Sagayama H; Motonaga K; Yamada Y; Uehara Y; Higaki Y; Takahashi H; Tanaka H
Int J Environ Res Public Health, 16 Dec. 2020, 17(24):E9433, Refereed - 福岡大学病院におけるHALリハビリテーションの現況 単関節HAL(Single Joint Hybrid Assistive Limb)を使用した在宅リハビリテーション
百武 光一; 齊田 和哉; 福田 宏幸; 渡邊 淳子; 上原 吉就; 森下 登史; 井上 亨
臨牀と研究, Dec. 2020, 97(12):1578 - 1582 - ファブリー病の診断と治療効果判定における心筋生検の有用性 〜心筋生検からGL-3の蓄積を考える〜
上原吉就
Cardiologist Fabry Expert Meeting 記録集, 01 Dec. 2020, :1 - 6 - 循環器疾患 total management in Nanakuma「高血圧治療とミネラルコルチコイドブロッカー (MRB) の位置づけ」
上原吉就
城南区医師会誌「城南」, 30 Sep. 2020, (120):22 - 22 - 特集「運動強度」の考え方と設定法 〜 安全かつ簡易に運動強度を測定する新指標の開発
上原吉就
コーチング・クリニック, 26 Sep. 2020, 34(11):14 - 17
Lead - 疲労およびオーバートレーニング症候群の評価方法に関する研究 ー 心電図周波数解析を活用した新たな評価方法の検討
田上友季也; 畑本陽一; 上原吉就
デサントスポーツ科学, 07 Sep. 2020, 41:159 - 167, Refereed - Horizontal Transmission of Hepatitis B Virus Genotype C Among Members of a Wrestling Club in Japan.
Takata K; Yamauchi E; Shakado S; Uehara Y; Fukuda H; Yamauchi R; Tsuchiya N; Kunimoto H; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Sakisaka S; Hirai F
Am J Case Rep, 31 Aug. 2020, 21:e925044, Refereed - Effects of inosine monophosphate and exercise training on neuronal nitric oxide synthase in the mouse brain
Yuki Tomiga; Kazuya Sakai; Shihoko Nakashima; Yoshinari Uehara; Kentaro Kawanaka; Yasuki Higaki
Neuroscience Letters, Aug. 2020, 734:135083 - 135083, Refereed - Feasibility of single and combined rehabilitation using transcranial direct current stimulation for chronic stroke
Hyakutake K; Morishita T; Saita K; Ogata T; Uehara Y; Shiota E; Inoue T
SAGE Open Medicine, 07 Jul. 2020, 8:2050312120940546 - 2050312120940546, Refereed - 高齢者の運動療法の有用性のエビデンスと実践の課題
小松知広; 道下竜馬; 上原吉就
日本臨床, Jul. 2020, 78(増刊号2):52 - 57, Refereed - 特集 熱中症予防のために 〜 暑い夏の運動療法
山本泰暉; 上原吉就
糖尿病療養指導のための DM Ensemble, 28 May 2020, 9(4):21 - 27, Refereed - Cognitive Impairment during High-Intensity Exercise: Influence of Cerebral Blood Flow.
Komiyama T; Tanoue Y; Sudo M; Costello JT; Uehara Y; Higaki Y; Ando S
Med Sci Sports Exerc., Mar. 2020, 52(3):561 - 568, Refereed - 第１２回 先輩医師と話そう！ In Fukuoka 「仕事と趣味の両立」
上原吉就
福岡県医報, Jan. 2020, 1523(6):35 - 35
Lead - Doctor's Voice vol. 1： 印象に残った患者さんとのエピソード
上原吉就
季刊 Doctor's eye, Jan. 2020, 55:34 - 医療をつなぐ現場から 〜 多科・多職種連携で取り組むファブリー病診療
井上貴仁; 上原吉就
てとてををつなぐ情報誌, Jan. 2020, (創刊号):3 - 6 - What Kind of Probucol Affects Normalizing Male Birth?
Komatsu T; Uehara Y
J Atheroscler Thromb, 01 Jan. 2020, 27(1):4 - 5, Refereed - Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.
Suematsu Y; Kawachi E; Idemoto Y; Matsuo Y; Kuwano T; Kitajima K; Imaizumi S; Kawamura A; Saku K; Uehara Y; Miura SI
Int J Cardiol., 15 Dec. 2019, 297:111 - 117, Refereed - One-week, but not 12-hours, cast immobilization alters promotor DNA methylation patterns in the nNOS gene in mouse skeletal muscle
Tomiga Y; Ito A; Sudo M; Ando S; Eshima H; Sakai K; Nakashima S; Uehara Y; Tanaka H; Soejima H; Higaki Y
J Physiol, 01 Nov. 2019, 597(21):5145 - 5159, Refereed - The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
Satoshi Umemura; Hisatomi Arima; Shuji Arima; Kei Asayama; Yasuaki Dohi; Yoshitaka Hirooka; Takeshi Horio; Satoshi Hoshide; Shunya Ikeda; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Yoshio Iwashima; Hisashi Kai; Kei Kamide; Yoshihiko Kanno; Naoki Kashihara; Yuhei Kawano; Toru Kikuchi; Kazuo Kitamura; Takanari Kitazono; Katsuhiko Kohara; Masataka Kudo; Hiroo Kumagai; Kiyoshi Matsumura; Hideo Matsuura; Katsuyuki Miura; Masashi Mukoyama; Satoko Nakamura; Takayoshi Ohkubo; Yusuke Ohya; Takafumi Okura; Hiromi Rakugi; Shigeyuki Saitoh; Hirotaka Shibata; Tatsuo Shimosawa; Hiromichi Suzuki; Shori Takahashi; Kouichi Tamura; Hirofumi Tomiyama; Takuya Tsuchihashi; Shinichiro Ueda; Yoshinari Uehara; Hidenori Urata; Nobuhito Hirawa
Hypertension research : official journal of the Japanese Society of Hypertension, Sep. 2019, 42(9):1235 - 1481, Refereed - Anxiety-like behaviors and hippocampal nNOS in response to diet-induced obesity combined with exercise.
Tomiga Y; Yoshimura S; Ra SG; Takahashi Y; Goto R; Kugimoto I; Uehara Y; Kawanaka K; Higaki Y
J Physiol Sci., Sep. 2019, 69(5)(5):711 - 722, Refereed - Association between breakfast skipping and postprandial hyperglycaemia after lunch in healthy young individuals.
Ogata H; Hatamoto Y; Goto Y; Tajiri E; Yoshimura E; Kiyono K; Uehara Y; Kawanaka K; Omi N; Tanaka H
Br J Nutr, 28 Aug. 2019, 122(4):431 - 440, Refereed - Running with a smile: The "niko niko pace" for promoting good health
Yukiya Tanoue; Keisuke Shiose; Yoshinari Uehara
Nishinihon Journal of Urology, 01 Aug. 2019, 81(4):421 - 428 - 長期にわたる収縮期血圧の変動は中高年男性の腎機能低下を助長する
道下竜馬; 松田拓朗; 上原吉就; 森戸夏美; 仁位隆信; 檜垣靖樹
日本臨床生理学会雑誌, 01 Aug. 2019, 49(3):143 - 150, Refereed - ニコニコペース®運動と健康づくり
田上友季也; 塩瀬圭佑; 上原吉就
西日本泌尿器科 別冊, 01 Aug. 2019, 81(4):421 - 428, Refereed - Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Satoshi Imaizumi; Yuhei Shiga; Masahiro Ogawa; Hideto Sako; Yoshihisa Nagata; Akira Matsunaga; Tetsuro Shirotani; Fumihiro Hoshino; Eiji Yahiro; Yuko Uehara; Natsumi Morito; Hiroyuki Tanigawa; Dai Shimono; Mikio Fukushima; Hidekazu Sugihara; Kenji Norimatsu; Takaaki Kusumoto; Keijiro Saku; Shin-Ichiro Miura
Heart and vessels, Apr. 2019, 34(4):698 - 710 - Corrigendum to "Short- and long-term effects of high-fat diet feeding and voluntary exercise on hepatic lipid metabolism in mice" [Biochem. Biophys. Res. Commun. 507 (2018) 291-296].
Saki Yoshimura; Shihoko Nakashima; Yuki Tomiga; Shotaro Kawakami; Yoshinari Uehara; Yasuki Higaki
Biochemical and biophysical research communications, 26 Mar. 2019, 511(1):202 - 204, Refereed - Effects of home-based robotic therapy involving the single-joint hybrid assistive limb robotic suit in the chronic phase of stroke: A pilot study
Hyakutake K; Morishita T; Saita K; Fukuda H; Shiota E; Higaki Y; Inoue T; Uehara Y
Biomed Res Int., 18 Mar. 2019, 5462694:1 - 9, Refereed
Last - 「一目瞭然！目で診る症例」問題
上原裕子; 坂本道男; 上原吉就
日内会誌, 10 Feb. 2019, 108(2):297 - 300, Refereed
Last - Effect of exercise intensity on renal blood flow in patients with chronic kidney disease stage 2.
Kotoku K; Yasuno T; Kawakami S; Fujimi K; Matsuda T; Nakashima S; Uehara Y; Tanaka H; Saito T; Higaki Y
Clin Exp Nephrol., 07 Feb. 2019, 23(5):621 - 628, Refereed - Short- and long-term effects of high-fat diet feeding and voluntary exercise on hepatic lipid metabolism in mice.
Saki Yoshimura; Shihoko Nakashima; Yuki Tomiga; Shotaro Kawakami; Yoshinari Uehara; Yasuki Higaki
Biochemical and biophysical research communications, 09 Dec. 2018, 507(1-4):291 - 296, Refereed - 人工HDLの中性脂肪へおよぼす影響の検討
上原吉就; 朔啓二郎; 浦田秀則; 小川正浩; 鍋島茂樹
福岡大学研究部論集, Dec. 2018, 6(1) - 激しい運動中の認知機能障害は脳血流量減少と関連しない(Impaired cognitive function during intense exercise is not associated with decreased cerebral blood flow)
Ando Soichi; Komiyama Takaaki; Tanoue Yukiya; Sudo Mizuki; Uehara Yoshinari; Tanaka Hiroaki; Higaki Yasuki
The Journal of Physical Fitness and Sports Medicine, Nov. 2018, 7(6):332 - 332 - 高脂肪食摂取や運動トレーニング介入が情動性に及ぼす影響 ―ランウェイテストによる評価―
冨賀裕貴; 高橋佑莉; 吉村咲紀; 後藤里奈; 釘本郁美; 上原吉就; 川中健太郎; 田中宏暁; 檜垣靖樹
福岡大学スポーツ科学研究, Nov. 2018, 49(1):1 - 13, Refereed - Depressor effect of the young leaves of Polygonum hydropiper Linn. in high-salt induced hypertensive mice
Devarajan S; Yahiro E; Uehara Y; Kuroda R; Hirano Y; Nagata K; Miura S; Saku K; Urata H
Biomedicine & Pharmacotherapy, 11 Mar. 2018, 102:1182 - 1187, Refereed - Association between exercise intensity and renal blood flow evaluated using ultrasound echo
Shotaro Kawakami; Tetsuhiko Yasuno; Takuro Matsuda; Kanta Fujimi; Ai Ito; Saki Yoshimura; Yoshinari Uehara; Hiroaki Tanaka; Takao Saito; Yasuki Higaki
Clinical and Experimental Nephrology, 10 Mar. 2018, 22(5):1061 - 1068, Refereed - Behavioral defects in a DCTN1G71A transgenic mouse model of Perry syndrome.
Mishima T; Deshimaru M; Watanabe T; Kubota K; Kinoshita-Kawada M; Yuasa-Kawada J; Takasaki K; Uehara Y; Jinno S; Iwasaki K; Tsuboi Y
Neurosci Lett., 19 Dec. 2017, 666:98 - 103, Refereed - 経時的CT撮影による肝脂肪蓄積の評価と自発的運動の効果
吉村咲紀; 冨賀裕貴; 中島志穂子; 伊藤愛; 川上翔太郎; 田中宏暁; 上原吉就; 檜垣靖樹
体力科学, Aug. 2017, 66(4):283 - 291, Refereed - Exercise training rescues high fat diet-induced neuronal nitric oxide synthase expression in the hippocampus and cerebral cortex of mice
Yuki Tomiga; Saki Yoshimura; Ai Ito; Shihoko Nakashima; Kentaro Kawanaka; Yoshinari Uehara; Hiroaki Tanaka; Yasuki Higaki
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, Jun. 2017, 66:71 - 77, Refereed - Improved 68Ga‐labeling method using ethanol addition: Application to the α‐helical peptide DOTA‐FAMP
Koki Hasegawa; Emi Kawachi; Yoshinari Uehara; Tsuyoshi Yoshida; Satoshi Imaizumi; Masahiro Ogawa; Shin-ichiro Miura; Keijiro Saku
Journal of Labelled Compounds and Radiopharmaceuticals, Jan. 2017, 60(1):55 - 61, Refereed - Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
Kenji Norimatsu; Takashi Kuwano; Shin-ichiro Miura; Tomohiko Shimizu; Yuhei Shiga; Yasunori Suematsu; Yuiko Miyase; Sen Adachi; Ayumi Nakamura; Satoshi Imaizumi; Atsushi Iwata; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
HEART AND VESSELS, Jan. 2017, 32(1):30 - 38, Refereed - Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
Kenji Norimatsu; Takashi Kuwano; Shin-ichiro Miura; Tomohiko Shimizu; Yuhei Shiga; Yasunori Suematsu; Yuiko Miyase; Sen Adachi; Ayumi Nakamura; Satoshi Imaizumi; Atsushi Iwata; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
HEART AND VESSELS, Jan. 2017, 32(1):30 - 38 - Improved 68 Ga-labeling method using ethanol addition: Application to the α-helical peptide DOTA-FAMP.
Koki Hasegawa; Emi Kawachi; Yoshinari Uehara; Tsuyoshi Yoshida; Satoshi Imaizumi; Masahiro Ogawa; Shin-ichiro Miura; Keijiro Saku
Journal of Labelled Compounds and Radiopharmaceuticals, Jan. 2017, 60(1):55 - 61 - Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice
Masaki Goto; Shin-ichiro Miura; Yasunori Suematsu; Yoshiaki Idemoto; Kouhei Takata; Satoshi Imaizumi; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Oct. 2016, 220:602 - 607, Refereed - Effects of environmental enrichment in aged mice on anxiety-like behaviors and neuronal nitric oxide synthase expression in the brain
Yuki Tomiga; Ai Ito; Mizuki Sudo; Soichi Ando; Akino Maruyama; Shihoko Nakashima; Kentaro Kawanaka; Yoshinari Uehara; Akira Kiyonaga; Hiroaki Tanaka; Yasuki Higaki
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Aug. 2016, 476(4):635 - 640, Refereed - Association between dental caries and out-of-hospital cardiac arrests of cardiac origin in Japan
Yasunori Suematsu; Japanese Circulation Society Resuscitation Science Study (JCS-ReSS) Group; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Masahiro Ogawa; Naohiro Yonemoto; Hiroshi Nonogi; Ken Nagao; Takeshi Kimura; Keijiro Saku
Journal of Cardiology, 01 Apr. 2016, 67(4):384 - 391, Refereed - The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway
Kohei Takata; Satoshi Imaizumi; Emi Kawachi; Eiji Yahiro; Yasunori Suematsu; Tomohiko Shimizu; Satomi Abe; Yoshino Matsuo; Kyoko Nakajima; Tetsuhiko Yasuno; Shiro Jimi; Bo Zhang; Yoshinari Uehara; Shin-ichiro Miura; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Mar. 2016, 207:317 - 325, Refereed - A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway
Yasunori Suematsu; Shin-ichiro Miura; Kohei Takata; Tomohiko Shimizu; Takashi Kuwano; Satoshi Imaizumi; Yoshino Matsuo; Eiji Yahiro; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Jan. 2016, 202:810 - 816, Refereed - High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases
Masahiro Ikenaga; Yasuki Higaki; Keijiro Saku; Yoshinari Uehara
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23(4):385 - 394, Refereed
Last - Addition of a nitric oxide donor to an angiotensin II type 1 receptor blocker may cancel its blood pressure-lowering effects
Eiji Yahiro; Shin-Ichiro Miura; Yasunori Suematsu; Yoshino Matsuo; Tadaaki Arimura; Takashi Kuwano; Satoshi Imaizumi; Atsushi Iwata; Yoshinari Uehara; Keijiro Saku
International Heart Journal, 02 Dec. 2015, 56(6):656 - 660, Refereed - Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension
Sankar Devarajan; Eiji Yahiro; Yoshinari Uehara; Shigehisa Habe; Akira Nishiyama; Shin-ichiro Miura; Keijiro Saku; Hidenori Urata
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, Dec. 2015, 309(11):H1987 - H1996, Refereed - Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension
Yuhei Shiga; Shin-ichiro Miura; Kenji Norimatsu; Yuka Hitaka; Itsuki Nagata; Rie Koyoshi; Joji Morii; Takashi Kuwano; Yoshinari Uehara; Asao Inoue; Tetsuro Shirotani; Kazuaki Fujisawa; Eiyu Matsunaga; Keijiro Saku
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, Dec. 2015, 16(4):1078 - 1084, Refereed - プロからプロへ：臨床各科のの一線医師同士が日常診療の疑問点を検証 人工HDLの開発状況
上原吉就
日本医事新報, 28 Nov. 2015, (4779):57 - 58 - High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides
Yoshinari Uehara; Giulia Chiesa; Keijiro Saku
CIRCULATION JOURNAL, Nov. 2015, 79(12):2523 - 2528, Refereed
Lead - Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo
Tomohiko Shimizu; Hiroyuki Tanigawa; Shin-ichiro Miura; Takashi Kuwano; Kohei Takata; Yasunori Suematsu; Satoshi Imaizumi; Eiji Yahiro; Bo Zhang; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Aug. 2015, 192:82 - 88, Refereed - Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients From the FU-Registry
Amane Ike; Kazuyuki Shirai; Hiroaki Nishikawa; Atushi Iwata; Eiji Yahiro; Makoto Sugihara; Akira Kawamura; Yoshinari Uehara; Bo Zhang; Masahiro Ogawa; Ken Mori; Shin-ichiro Miura; Keijiro Saku
JOURNAL OF CARDIOLOGY, May 2015, 65(5-6):390 - 396, Refereed - 新規HDL-C増加薬(2) -合成HDLとミメティックペプチド.
今泉 聡; 上原 吉就; Giulia Chiesa; 朔 啓二郎
血管医学, 10 Apr. 2015, 16(1):45 - 51 - Comparison of 64Cu and 68Ga for Molecular Imaging of Atherosclerosis using the Apolipoprotein A-I Mimetic Peptide FAMP.
Yahiro E; Kawachi E; Miura S; Kuwano T; Imaizumi S; Iwata A; Hasegawa K; Yano T; Watanabe Y; Uehara Y; Saku K
J Cardiovasc Dis Diag, 2015, 3:201, Refereed - Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: From the FU-Registry
Itsuki Nagata; Amane Ike; Hiroaki Nishikawa; Bo Zhang; Makoto Sugihara; Ken Mori; Atsushi Iwata; Akira Kawamura; Kazuyuki Shirai; Yoshinari Uehara; Masahiro Ogawa; Shin-ichiro Miura; Keijiro Saku
JOURNAL OF CARDIOLOGY, Jan. 2015, 65(1-2):105 - 111, Refereed - Induction of endothelial tube formation and anti-inflammation by newly developed apolipoprotein A-I mimetic peptide
Shin-ichiro Miura; Yasunori Suematsu; Yoshino Matsuo; Satoshi Imaizumi; Eiji Yahiro; Yoshinari Uehara; Keijiro Saku
IJC Metabolic and Endocrine, 01 Nov. 2014, 5:70 - 72, Refereed - Rosuvastatin Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Promotes Reverse Cholesterol Transport in Macrophage Cells in Mice Fed a High-Fat Diet
Tomohiko Shimizu; Shin-ichiro Miura; Hiroyuki Tanigawa; Takashi Kuwano; Bo Zhang; Yoshinari Uehara; Keijiro Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, Oct. 2014, 34(10):2246 - +, Refereed - High-density lipoprotein and atherosclerosis: Roles of lipid transporters
Uehara Y; Saku K
World J Cardiol, Oct. 2014, 6(10):1049 - 1059, Refereed
Lead - 特集： HDL機能と病態・創薬 II. HDLを標的とした動脈硬化性疾患治療の現状と未来 ４．人工HDL
上原吉就; 朔 啓二郎
The Lipid, Jul. 2014, 25(3):86 - 94 - interview 研究の窓辺
上原吉就
血圧, Jun. 2014, 21(6):554 - 555 - 座談会 心血管インターベンション up-to-date
朔啓二郎; 小林欣夫; 河野知記; 仁位隆信; 西川宏明; 松尾邦浩; 上原吉就
治療, Jun. 2014, 96(3):212 - 219 - 心筋梗塞 最前線．
朔啓二郎; 小林欣夫; 河野知記; 仁位隆信; 松尾邦浩; 上原吉就; 西川宏明
Vascular Street, Jun. 2014, 9(2):1 - 4 - 最新肥満症学－基礎・臨床研究の最前線－禁煙と肥満
上原吉就; 朔 啓二郎
日本臨床, May 2014, 72(増刊号4):720 - 723 - 特集 心筋梗塞最前線 〜 心筋梗塞のリスクファクター
上原吉就; 朔 啓二郎
治療, Mar. 2014, 96(3):234 - 242 - アポ蛋白 A-I を標的とした新しい動脈硬化治療戦略：FAMP
上原吉就; 朔 啓二郎
J-ISCP 会誌「心血管薬物療法」, Mar. 2014, 2(1):3 - 8 - Comparison of the efficacy and safety of single-pill fixed-dose combinations of olmesartan/azelnidipine and valsartan/amlodipine in patients with hypertension (RENOVATE Study)
Itsuki Nagata; Yuhei Shiga; Shin-Ichiro Miura; Kenji Norimatsu; Yuka Hidaka; Seishi Morii; Takashi Kuwano; Asao Inoue; Kazuaki Fujisawa; Tetsuo Shirotani; Eiyu Matsunaga; Yoshinari Uehara; Keijiro Saku
Experimental and Clinical Cardiology, 2014, 20(1):1920 - 1938 - Associations between the consumption of different kinds of seafood and out-of-hospital cardiac arrests of cardiac origin in Japan
Yasunori Suematsu; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Masaki Tokunaga; Naohiro Yonemoto; Hiroshi Nonogi; Ken Nagao; Takeshi Kimura; Keijiro Saku
IJC Heart and Vessels, 2014, 2:8 - 14, Refereed - Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP
Eiji Yahiro; Yoshinari Uehara; Emi Kawachi; Setsuko Ando; Shin-ichiro Miura; Keijiro Saku
IJC Heart and Vessels, 2014, 4(1):135 - 137, Refereed
Lead - Impact of cigarette smoking cessation on high-density lipoprotein functionality: – VN-SEESAW-HDL –
Kohei Takata; Satoshi Imaizumi; Emi Kawachi; Yasunori Suematsu; Tomohiko Shimizu; Satomi Abe; Yoshino Matsuo; Hitomi Tsukahara; Keita Noda; Eiji Yahiro; Bo Zhang; Yoshinari Uehara; Shin-Ichiro Miura; Keijiro Saku
Circulation Journal, 2014, 78(12):2955 - 2962, Refereed - A relative difference in blood pressure between arms by synchronal measurement is associated with hypertension
T.Yamamoto; SI.Miura; Y.Shiga; Y.Nagata; Y.Miyase; Y.Suematsu; Y.Uehara; K.Saku
Exp Clin Cardiol, 2014, 20:6574 - 6578, Refereed - Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study)
Tanaka T; Miura S; Tanaka M; Uehara Y; Hirano T; Saku K
J Clin Med Res., Dec. 2013, 5(6):432 - 40, Refereed - Dental Caries is Associated With Out-of hospital Cardiac Arrest of Cardiac Origin, but not Noncardiac Origin: From the All-Japan Utstein Registry
Suematsu Yasunori; Miura Shin-ichiro; Uehara Yoshinari; Zhang Bo; Yonemoto Naohiro; Nonogi Hiroshi; Nagao Ken; Kimura Takeshi; Saku Keijiro
CIRCULATION, 26 Nov. 2013, 128(22), Refereed - Comparison of 68Ga and 64Cu for Molecular Imging of Atherosclerosis using apo A-I mimetic Peptide FAMP
Yahiro, Eiji; Uehara, Yoshinari; Kawachi, Emi; Hasegawa, Koki; Ando, Setsuko; Miura, Shin-ichiro; Saku, Keijiro
CIRCULATION, Nov. 2013, 128(22), Refereed - Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein – Novel HDL-Directed Pharmacological Intervention and Exercise –
Bo Zhang; Emi Kawachi; Shin-ichiro Miura; Yoshinari Uehara; Akira Matsunaga; Masahide Kuroki; Keijiro Saku
CIRCULATION JOURNAL, Nov. 2013, 77(11):2651 - 2663, Refereed - 「一目瞭然！目で診る症例」問題
日高有香; 上原吉就; 朔 啓二郎
日内会誌, Oct. 2013, 102(11):3013 - 3015, Refereed - 日本のタバコ消費の経時変化と心疾患死亡率の関係
張 波; 徳永 昌樹; 上原 吉就; 三浦 伸一郎; 朔 啓二郎
循環器専門医, Sep. 2013, 21(2):341 - 343, Refereed - 脂質異常症-基礎・臨床研究の最新知見-．
上原吉就; 朔啓二郎
日本臨床, Jun. 2013, 71(増刊号3):613 - 619 - Induction of tissue angiotensin Ⅱ-forming activity in two-kidney, one-clip hypertensive hamster model
Yoshinari Uehara; Kanta Fujimi; Eiji Yahiro; Satomi Abe; Sankar Devarajan; Keijiro Saku; Hidenori Urata
World J Hypertens, May 2013, 3(2):9 - 17, Refereed
Lead - Anti-smoking declaration 2013.
Anti-Smoking; Promotion Committee of the; Japanese Circulation Society; Saku K; Iida M; Uehara Y; Ebina T; Murohara T; Takihara K; Higaki J; Takahashi Y; Fujiwara H
Circ J, Feb. 2013, 77(3):559 - 60, Refereed - [Series: diagnosis at a glance].
Yuka Hitaka; Yoshinari Uehara; Keijiro Saku
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2013, 102(11):3013 - 3015 - Chymase inhibitors
Eiji Yahiro; Shin-ichiro Miura; Satoshi Imaizumi; Yoshinari Uehara; Keijiro Saku
Current Pharmaceutical Design, 2013, 19(17):3065 - 3071, Refereed - Non-ACE pathway-induced angiotensin II production
Yoshinari Uehara; Shin-ichiro Miura; Eiji Yahiro; Keijiro Saku
Current Pharmaceutical Design, 2013, 19(17):3054 - 3059, Refereed
Lead - Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers
Satoshi Imaizumi; Shin-ichiro Miura; Eiji Yahiro; Yoshinari Uehara; Issei Komuro; Keijiro Saku
Current Pharmaceutical Design, 2013, 19(17):3002 - 3008, Refereed - Novel molecular imaging of atherosclerosis with Gallium-68-labeled Apolipoprotein A-I mimetic peptide and positron emission tomography
Kawachi, E.; Uehara, Y.; Hasegawa, K.; Yahiro, E.; Ando, S.; Wada, Y.; Yano, T.; Nishikawa, H.; Shiomi, M.; Miura, S.; Watanabe, Y.; Saku, K.
Circulation Journal, 2013, 77(6):1482 - 9, Refereed
Lead - FAMP, a Novel ApoA-I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE-Deficient Mice
Yoshinari Uehara; Setsuko Ando; Eiji Yahiro; Kosuke Oniki; Makoto Ayaori; Satomi Abe; Emi Kawachi; Bo Zhang; Seijiro Shioi; Hiroyuki Tanigawa; Satoshi Imaizumi; Shin-Ichiro Miura; Keijiro Saku
Journal of the American Heart Association, 2013, 2(3):e000048, Refereed
Lead - 特別報告 【第12回禁煙推進セミナー】 〈受動喫煙：労働安全と生活安全の側面から〉1．日本のタバコ消費の変化と心疾患死亡率の関係．
張波; 徳永昌樹; 上原吉就; 三浦伸一郎; 朔啓二郎
循環器専門医, 2013, 21(2):339 - 340 - 研究機関研究所近況 産学官連携研究機関 心臓・血管研究所 アンジオテンシンⅡ1型受容体ブロッカーのドラッグエフェクト．
三浦伸一郎; 上原吉就; 小川正浩; 出石宗仁; 田代忠; 朔啓二郎
Research, 2013, 18(3):31 - 33 - 研究機関研究所近況 産学官連携研究機関 心臓・血管研究所 魚消費と院外心停止の関連について．
末松保憲; 上原吉就; 三浦伸一郎; 瀬川波子; 朔啓二郎
Research, 2013, 18(1):38 - 40 - Anti-Smoking Declaration 2013 -A Message From the Japanese Circulation Society-.
The Anti-Smoking; Promotion Committee of the; Japanese Circulation Society; Saku K; Iida M; Uehara Y; Ebina T; Murohara T; Takihara K; Higaki J; Takahashi Y; Fujiwara H
Vascular Street, 2013, 8(4):1 - 4 - Anti-cholinergics for axial symptoms in Parkinson's disease after subthalamic stimulation
Yasuhiko Baba; Masa-aki Higuchi; Hiroshi Abe; Kouzou Fukuyama; Rieko Onozawa; Yoshinari Uehara; Tooru Inoue; Tatsuo Yamada
CLINICAL NEUROLOGY AND NEUROSURGERY, Dec. 2012, 114(10):1308 - 1311, Refereed - Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension
Yuhei Shiga; Shin-ichiro Miura; Ryoko Mitsutake; Kenji Norimatsu; Itsuki Nagata; Tadaaki Arimura; Tomohiko Shimizu; Joji Morii; Takashi Kuwano; Yoshinari Uehara; Asao Inoue; Tetsuro Shirotani; Kazuaki Fujisawa; Eiyu Matsunaga; Keijiro Saku
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, Sep. 2012, 13(3):394 - 400, Refereed - Reactivity of Direct Assays for Low-Density Lipoprotein (LDL) Cholesterol Toward Charge-Modified LDL in Hypercholesterolemia
Bo Zhang; Emi Kawachi; Akira Matsunaga; Satoshi Imaizumi; Keita Noda; Yoshinari Uehara; Shin-ichiro Miura; Kazuhiko Yoshinaga; Masahide Kuroki; Keijiro Saku
CIRCULATION JOURNAL, Sep. 2012, 76(9):2241 - 2248, Refereed - Retinoic acid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages
Makoto Ayaori; Emi Yakushiji; Masatsune Ogura; Kazuhiro Nakaya; Tetsuya Hisada; Harumi Uto-Kondo; Shunichi Takiguchi; Yoshio Terao; Makoto Sasaki; Tomohiro Komatsu; Maki Iizuka; Makiko Yogo; Yoshinari Uehara; Hiroyuki Kagechika; Tsuyoshi Nakanishi; Katsunori Ikewaki
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, Apr. 2012, 1821(4):561 - 572, Refereed - Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension
Yuhei Shiga; Shin-ichiro Miura; Ryoko Mitsutake; Yoshinari Uehara; Asao Inoue; Keijiro Saku
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, Mar. 2012, 13(1):107 - 112, Refereed - 脂質異常症（高脂血症）
上原吉就; 朔 啓二郎
循環器疾患最新の治療 2012-2013, Mar. 2012, :487 - 494 - アガルシダーゼαにエゼチミブを併用したFabry病の1例
渡辺 廉也; 高畑正文; 伊藤 建二; 安部 泰弘; 笹冨 佳江; 小河原 悟; 上原 吉就; 久野 敏; 斉藤 喬雄
Therapeutic Research, Feb. 2012, 33(2):163 - 165 - Comparison of the Efficacy and Safety of Irbesartan and Olmesartan in Patients With Hypertension (EARTH Study)
Joji Morii; Shin-ichiro Miura; Yuhei Shiga; Makoto Sugihara; Tadaaki Arimura; Hideto Sako; Bo Zhang; Yoshinari Uehara; Keijiro Saku
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34(5):342 - 349, Refereed - 動脈硬化フロンティア2012 -改訂｢動脈硬化性疾患予防ガイドライン2012年版｣：臨床にどう生かす？-
朔啓二郎; 土橋卓也; 坂本知浩; 上原吉就; 西川宏明
Vascular Street, 2012, 7(11):1 - 6 - 地中海ダイエットは心臓にやさしい！
上原吉就; 朔啓二郎
Vascular Street, 2012, 7(10):1 - 4 - 降圧療法におけるARB/利尿薬配合錠の有用性．
三浦伸一郎; 志賀悠平; 今泉聡; 上原吉就; 朔啓二郎
Progress in Medicine 第10号 別刷, 2012, 32(10):127 - 133 - 低HDL-C血症 －コレステロール逆転送系と動脈硬化を識る－．
高田耕平; 上原吉就; 朔啓二郎
Heart View, 2012, 16(10):20 - 26 - 研究機関研究所近況 産学官連携研究機関 心臓・血管研究所 福岡大学発の新規アポA-1模倣ペプチド(FAMP)の開発 〜動脈硬化治療薬および動脈硬化診断薬としての可能性〜
上原吉就; 八尋英二; 三浦伸一郎; 安東勢津子; 朔啓二郎
Research, 2012, 17(1):29 - 30 - 特集 先進循環器病治療研究会 「血管を護るための糖尿病治療戦略〜インクレチン関連薬を中心に〜」
朔啓二郎; 野見山崇; 仁位隆信; 岡部眞典; 白井和之; 小川正浩; 上原吉就; 河村彰; 西川宏明; 岩田敦; 佐光英人; 安田智生; 藤見幹太; 森戸夏美; 八尋英二; 光武良晃; 今泉聡
Vascular Street, 2012, 7(3):1 - 6 - TG-rich HDL.
今泉聡; 上原吉就; 朔啓二郎
Heart View, 2012, 16(12(増刊号)):250 - 253 - 循環器・代謝疾患分子標的グループ
岩本隆宏; 喜多紗斗美; 堀江一郎; 後藤雄輔; 朔啓二郎; 三浦伸一郎; 上原吉就; 小川正浩; 西川宏明; 河村彰; 岩田敦
福岡大学基盤研究機関 先端分子医学研究所 2011年度年報, 2012, :97 - 115 - Giant Thrombus Filling the Pulmonary Trunk
Ayumi Nakamura; Yoshinari Uehara; Akira Kawamura; Keijiro Saku
INTERNAL MEDICINE, 2012, 51(3):333 - 333, Refereed
Corresponding - 低HDL-C血症 -コレステロール逆転送系と動脈硬化を識る-
TAKATA Kohei; UEHARA Yoshinari; SAKU Keijiro
Heart View, 2012 - Novel System for the Molecular Imaging of Atherosclerotic Plaque with Ga-68-DOTA-ApoA-I Mimetic Peptide (-FAMP)
Yahiro, Eiji; Uehara, Yoshinari; Hasegawa, Koki; Kawachi, Emi; Yano, Tsuneo; Watanabe, Yasuyoshi; Miura, Shin-ichiro; Saku, Keijiro
CIRCULATION, Nov. 2011, 124(21), Refereed - Tangier Disease
Y.Uehara; B.Zhang; K.Saku
Advances in the Study of Genetic Disorders, Nov. 2011, 8:239 - 254, Refereed - Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease
Y. Baba; M. -A. Higuchi; K. Fukuyama; H. Abe; Y. Uehara; T. Inoue; T. Yamada
EUROPEAN JOURNAL OF NEUROLOGY, Nov. 2011, 18(11):1299 - 1303, Refereed - Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies.
Hideki Ozasa; Makoto Ayaori; Maki Iizuka; Yoshio Terao; Harumi Uto-Kondo; Emi Yakushiji; Shunichi Takiguchi; Kazuhiro Nakaya; Tetsuya Hisada; Yoshinari Uehara; Masatsune Ogura; Makoto Sasaki; Tomohiro Komatsu; Shunpei Horii; Seibu Mochizuki; Michihiro Yoshimura; Katsunori Ikewaki
ATHEROSCLEROSIS, Nov. 2011, 219(1):141 - 150, Refereed - Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits
Atsushi Iwata; Shin-ichiro Miura; Bo Zhang; Satoshi Imaizumi; Yoshinari Uehara; Masashi Shiomi; Keijiro Saku
ATHEROSCLEROSIS, Oct. 2011, 218(2):300 - 307, Refereed - 心保護を考慮した厳格な降圧の重要性
上原吉就; 島田和幸; 伊藤浩
Medical Tribune, Oct. 2011, 44(43):10 - 11 - A Randomized, Double-blind, Controlled, Comparative Trial of Formula Food Containing Soy Protein Versus Milk Protein in Visceral Fat Obesity: FLAVO study
Masaya Takahira; Keita Noda; Mikio Fukushima; Bo Zhang; Ryoko Mitsutake; Yoshinari Uehara; Masahiro Ogawa; Tatsuyuki Kakuma; Keijiro Saku
Circ J, Aug. 2011, 75(9):2235 - 43, Refereed - Possibility of increasing cholesterol efflux by adiponectin and its receptors through the ATP binding cassette transporter A1 in HEK293T cells
Ken Kitajima; Shin-ichiro Miura; Toshimasa Yamauchi; Yoshinari Uehara; Yoshihiro Kiya; Kerry-Anne Rye; Takashi Kadowaki; Keijiro Saku
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Jul. 2011, 411(2):305 - 311, Refereed - HDL研究からHDL治療へ
朔 啓二郎; 上原吉就; 三浦伸一郎; 谷川宏之; 張波; 木谷嘉博; 今泉聡; Srinivasa T.Reddy
循環器専門医, Apr. 2011, 19(1):8 - 17 - Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography
Ryoko Mitsutake; Shin-ichiro Miura; Yuhei Shiga; Yoshinari Uehara; Keijiro Saku
JOURNAL OF CLINICAL HYPERTENSION, Mar. 2011, 13(3):198 - 204, Refereed - 特集／最新の高血圧薬物療法 － 合併症を有する高血圧治療 脂質異常症
清水知彦; 上原吉就; 朔 啓二郎
臨牀と研究, Feb. 2011, 88(2):183 - 190 - AT1受容体拮抗薬＋Ca拮抗薬（ARB+CCB)降圧併用療法における家庭血圧・心拍数への効果の検討（COMBAT試験）
上原吉就; 馬場康彦; 岩田 敦; 森戸夏美; 張 波; 八尋英二; 三浦 伸一郎; 出石宗仁; 朔 啓二郎
THERAPEUTIC RESEARCH, Feb. 2011, 32(2):183 - 192, Refereed
Lead - A Pilot Assessment of Oxidative Stress Byproducts and Antioxidant Activities Among Indian Patients with Various Stages of Hypertension
Raman Saraswathi; Devarajan Sankar; Amanat Ali; Yoshinari Uehara; Satomi Abe; Ganapathy Sambandam; M. Ramakrishna Rao
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33(7):437 - 443, Refereed - Aortitis Syndrome with Vascular Anomaly Detected by MD-CT
Yuhei Shiga; Yoshinari Uehara; Ryoko Mitsutake; Keijiro Saku
INTERNAL MEDICINE, 2011, 50(19):2239 - 2239, Refereed - Comparison of the Efficacy and Safety of Single-Pill Fixed-Dose Combinations of Losartan/Hydrochlorothiazide and Valsartan/Hydrochlorothiazide in Patients with Hypertension (SALT-VAT Study)
Yuhei Shiga; Shin-ichiro Miura; Joji Morii; Takashi Kuwano; Ryoko Mitsutake; Yoshinari Uehara; Asao Inoue; Keijiro Saku
INTERNAL MEDICINE, 2011, 50(21):2477 - 2483, Refereed - Statins Induce the Gene Expression of Apolipoprotein A5 in HepG2 Cells.
Arishima H; Matsunaga A; Uehara Y; Niimura H; Zhang B; Ohwaki K; Hayashida K; Yoshimizu K; Saku K
Med.Bull.Fukuoka Univ. （福岡大学医学紀要）, 2011, 38(4):161 - 169 - 特集 動脈硬化リスク因子のupdate. HDLとその周辺
鬼木幸祐; 上原吉就; 朔啓二郎
循環器内科, 2011, 70(2):135 - 142 - 第5回 FUKUOKA Fibrate Forum (FFF) 「より良い脂質管理を目指して：フィブラート製剤の臨床的意義」
朔啓二郎; 横山信治; 三浦伸一郎; 秀平キヨミ; 上原吉就
Vascular Street, 2011, 6(5):1 - 6 - 座談会 ARB/Ca拮抗薬配合剤 レザルタスR配合錠への期待 心保護を考慮した厳格な降圧の重要性．
島田和幸; 伊藤浩; 上原吉就
Medical Tribune (2011.10.27号特別企画より転載), 2011 - THE HDL HANDBOOK; Biological Functions and Clinical Implications; Chapter 7: Apolipoprotein A-I Mutations
Akira Matsunaga; Yoshinari Uehara; Bo Zhang; Keijiro Saku
Academic Press (ELSEVIER), Aug. 2010, :133 - 151, Refereed - Free Fatty Acid Causes Leukocyte Activation and Resultant Endothelial Dysfunction Through Enhanced Angiotensin II Production in Mononuclear and Polymorphonuclear Cells
Yoko Azekoshi; Takanori Yasu; Saiko Watanabe; Tatsuya Tagawa; Satomi Abe; Ken Yamakawa; Yoshinari Uehara; Shinichi Momomura; Hidenori Urata; Shinichiro Ueda
HYPERTENSION, Jul. 2010, 56(1):136 - U218, Refereed - デキる医師の紹介・逆紹介スキル99
上原吉就; 朔 啓二郎
治療, Apr. 2010, 92(4月増刊):834 - 836 - Antioxidative capacity of hydrochlorothiazide and atenolol in long-term hypertension therapy
Devarajan Sankar; Amanat Ali; Sarawathi Raman; Yoshinari Uehara; Sambandam Ganapathy
J Chin Clin Med, Mar. 2010, 5(3):123 - 129, Refereed - Homocysteine-induced oxidative stress upregulates chymase in mouse mastocytoma cells
Kanta Fujimi; Yoshinari Uehara; Satomi Abe; Akira Kawamura; Sankar Devarajan; Shin-ichiro Miura; Keijiro Saku; Hidenori Urata
HYPERTENSION RESEARCH, Feb. 2010, 33(2):149 - 154, Refereed
Corresponding - Apolipoprotein A-I mutations
Akira Matsunaga; Yoshinari Uehara; Bo Zhang; Keijiro Saku
The HDL Handbook, 2010, :133 - 151, Refereed - Pharmacological Intervention Using Reconstituted High-Density Lipoprotein Changes in the Lipid Profile in Spontaneously Hypersensitive Rats
Satoshi Imaizumi; Yoshihiro Kiya; Shin-Ichiro Miura; Bo Zhang; Yoshino Matsuo; Yoshinari Uehara; Kerry-Anne Rye; Keijiro Saku
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32(3):202 - 208, Refereed - Significance of Serum High-Density Lipoprotein Cholesterol Levels for Diagnosis of Coronary Stenosis as Determined by MDCT in Patients with Suspected Coronary Artery Disease
Yuhei Shiga; Shin-ichiro Miura; Ryoko Mitsutake; Akira Kawamura; Yoshinari Uehara; Keijiro Saku
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17(8):870 - 878, Refereed - 研究報告 HDL治療の開発: コレステロール輸送体とアポA-Ⅰ模倣ペプチドを標的とした創薬開発
朔啓二郎; 上原吉就; 三浦伸一郎; 張波; 野田慶太; 西川宏明; 小川正浩; 河村彰; 北島研; 岩田敦; 細井薫; 出石宗仁
私立大学戦略的研究基盤形成支援事業 身体活動の研究拠点形成 身体活動の健康科学に関する総合研究 平成21年度 研究報告書 代表研究者 田中 宏暁, 2010, :118 - 121 - 酸化ストレスマーカーの診療への応用
朔啓二郎; 三浦伸一郎; 張波; 上原吉就; 野田慶太; 西川宏明; 小川正浩; 河村彰; 北島研; 岩田敦; 細井薫; 出石宗仁
FUPグローバルFUP ワンキャンパスプロジェクトテーマ⑥ 「バイオストレス応答の制御機構研究教育拠点」 2009年度 研究成果報告書, 2010, :70 - 73 - 生活習慣病は本当にエビデンス通りに治療するだけで良いのだろうか？
朔啓二郎; 弘世貴久; 三浦伸一郎; 河村彰; 上原吉就
Vascular Street, 2010, 5(4):1 - 4 - Acute coronary syndrome associated with essential thrombocythemia
Naoko Kumagai; Ryoko Mitsutake; Shin-ichiro Miura; Akira Kawamura; Yosuke Takamiya; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
JOURNAL OF CARDIOLOGY, Dec. 2009, 54(3):485 - 489, Refereed - HDL-Cの変化は本当に心臓病の発症と関連するか？
上原吉就; 朔 啓二郎
モダンフィジシャン, Nov. 2009, 29(11):1668 - 血中尿酸の高値は高血圧症を引き起こすのか？
上原吉就; 朔 啓二郎
モダンフィジシャン, Nov. 2009, 29(12):1796 - Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study
Bo Zhang; Akira Matsunaga; David L. Rainwater; Shin-ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
JOURNAL OF LIPID RESEARCH, Sep. 2009, 50(9):1832 - 1841, Refereed - Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation
Makoto Sugihara; Shin-ichiro Miura; Yosuke Takamiya; Yoshihiro Kiya; Tadaaki Arimura; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
HYPERTENSION RESEARCH, Jul. 2009, 32(7):625 - 630, Refereed - 特集：HDLを再考する わが国のHDL関連遺伝子異常とCardiovascular Riskを知る
上原吉就; 朔啓二郎
Vascular Medicine, Apr. 2009, 5(2):100 - 105 - Newly developed PPAR-alpha agonist (R)-K-13675 inhibits the secretion of inflammatory markers without affecting cell proliferation or tube formation
Ken Kitajima; Shin-ichiro Miura; Yoshino Mastuo; Yoshinari Uehara; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2009, 203(1):75 - 81, Refereed - Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats
Yoshihiro Kiya; Shin-ichiro Miura; Satoshi Imaizumi; Yoshinari Uehara; Yoshino Matsuo; Satomi Abe; Shiro Jimi; Hidenori Urata; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2009, 203(1):137 - 144, Refereed - 高血圧 〜降圧と臓器保護作用からみた薬剤併用療法〜
上原吉就; 朔 啓二郎
MEDICAMENT NEWS, Jan. 2009, 1966:5 - 8 - A Postmenopausal Patient with Tangier Disease Developing Sjogren's Syndrome
Kiyomitsu Miyachi; Raleigh W. Hankins; Yoshinari Uehara; Bo Zhang; Keijiro Saku; Yasuhiko Homma; Hiroshi Shigematsu; Katsuhiko Mikoshiba
JOURNAL OF RHEUMATOLOGY, Jan. 2009, 36(1):208 - 210, Refereed - HDL代謝におけるABCA1とSR-BIの機能
上原吉就; 朔啓二郎
M.P. Medical Practice, Jan. 2009, 26(1):151 - Genotypic effect of ABCG1 gene promoter -257T> G polymorphism on coronary artery disease severity in Japanese men
Shoudai Furuyama; Yoshinari Uehara; Bo Zhang; Yasuhiko Baba; Satomi Abe; Takahiro Iwamoto; Shin-Ichiro Miura; Keijiro Saku
Journal of Atherosclerosis and Thrombosis, 2009, 16(3):194 - 200, Refereed
Corresponding - 酸化LDLに対するニフェジピンの役割
高宮陽介; 三浦伸一郎; 谷川宏之; 張波; 上原吉就; 朔啓二郎
THERAPEUTIC RESEARCH, 2009, 30(5):799 - 805 - HDL-Cを標的とした心臓病治療戦略：HDL-Cは上げるべきか？ 日本心臓病学会 誌上座談会
朔啓二郎; 三浦伸一郎; 上原吉就; 横山信治; 池脇克則
日本心臓病学会誌, Sep. 2008, 2(2):131 - 140 - 膵β細胞におけるABCA1コレステロール輸送体の役割
上原吉就; 朔啓二郎
Medical Practice, Aug. 2008, 25(8):1442 - ATP-binding cassette transporter G4 is highly expressed in microglia in Alzheimer's brain.
Uehara Y; Yamada T; Baba Y; Miura SI; Abe S; Kitajima K; Higuchi MA; Iwamoto T; Saku K
Brain Res, Jul. 2008, 1217C:239 - 246, Refereed
Lead - 大動脈瘤症候群における新たな知見
上原吉就; 朔啓二郎
Medical Practice, May 2008, 25(5):898 - Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats
Satoshi Imaizumi; Shin-ichiro Miura; Kazuto Nakamura; Yoshihiro Kiya; Yoshinari Uehara; Bo Zhang; Yoshino Matsuo; Hidenori Urata; Munehito Idelshi; Kerry-Anne Rye; Masataka Sata; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Apr. 2008, 51(16):1604 - 1612, Refereed - POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease
Yoshinari Uehara; Yoshio Tsuboi; Bo Zhang; Shin-ichiro Miura; Yasuhiko Baba; Masa-aki Higuchi; Tatsuo Yamada; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2008, 197(1):283 - 289, Refereed
Lead - 本態性高血圧患者のメタボリック因子に対するテルミサルタンの効果
上原吉就; 三浦 伸一郎; 藤野正礼; 岩田 敦; 河村 彰; 新村英也; 安田智生; 西川宏明; 松永 彰; 朔 啓二郎
Progress in Medicine, Mar. 2008, 28(3):783 - 787, Refereed
Lead - 高比重リポ蛋白（HDL)治療の確立
上原吉就; 瀬川波子; 松尾邦浩; 西川宏明; 三浦伸一郎; 朔啓二郎
Research, Mar. 2008, 13(1):31 - 33 - メタボリックシンドロームと心血管病リスクの関連
上原吉就; 朔啓二郎
Medical Practice, Feb. 2008, 25(2):344 - 本態性高血圧患者に対するロサルタンとヒドロクロロチアジド併用降圧療法の有用性
上原吉就; 三浦伸一郎; 藤野正礼; 岩田敦; 河村彰; 朔啓二郎
Progress in Medicine, 2008, 28(12):103 - 108 - 「エゼチミブのスタチン併用療法」
朔啓二郎; 上原吉就
Vascular Street, 2008, 3(9):1 - 6 - Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation
Yoshino Matsuo; Shin-Ichiro Miura; Akira Kawamura; Yoshinari Uehara; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, Sep. 2007, 194(1):159 - 168, Refereed - PSMA6遺伝子多型 〜新規心筋梗塞発症の関連因子
上原吉就; 朔 啓二郎
Medical Practice, Sep. 2007, 24(9):1640 - Effects of apoA-I/ phosphatidylcholine discs on charge-based LDL subfractions as characterized by capillary isotachophoresis
Zhang B; Uehara Y; Hida S; Miura SI; Rainwater DL; Segawa M; Kumagai K; Rye KA; Saku K
J Lipid Res., May 2007, 48(5):1175 - 89, Refereed - Strong linkage disequilibrium and association of-1131T > C and c.553G > T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population
Akira Matsunaga; Hiroaki Arishima; Hideya Niimura; Bo Zhang; Yoshinari Uehara; Kazuo Ohwaki; Mie Morita; Kazue Hayashida; Keijiro Saku
CIRCULATION JOURNAL, May 2007, 71(5):746 - 752, Refereed - Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis
Bo Zhang; Yoshinari Uehara; Satoru Hida; Shin-ichiro Miura; David L. Rainwater; Masaru Segawa; Koichiro Kumagai; Kerry-Anne Rye; Keijiro Saku
JOURNAL OF LIPID RESEARCH, May 2007, 48(5):1175 - 1189 - 心臓でのPPARαの作用
上原吉就; 朔啓二郎
Medical Practice, Apr. 2007, 24(4):742 - Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element
Yoshinari Uehara; Shin-ichiro Miura; Arnold von Eckardstein; Satomi Abe; Akihiro Fujii; Yoshino Matsuo; Stephan Rust; Stefan Lorkowski; Gerd Assmann; Tatsuo Yamada; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2007, 191(1):11 - 21, Refereed
Lead - 本態性高血圧患者の降圧療法におけるオルメサルタンへの切り替え効果
上原吉就; 三浦 伸一郎; 岩田 敦; 河村 彰; 藤野正礼; 松永 彰; 朔 啓二郎
Progress in Medicine, Mar. 2007, 27(3):639 - 643, Refereed - 患者が好むGEの処方法
上原吉就
治療, Mar. 2007, 89(3):505 - 508 - Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation
Keisuke Okamura; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Kunihiro Matsuo; Koichiro Kumagai; Keijiro Saku
CIRCULATION JOURNAL, Feb. 2007, 71(2):214 - 219, Refereed - Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation
Keisuke Okamura; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Kunihiro Matsuo; Koichiro Kumagai; Keijiro Saku
CIRCULATION JOURNAL, Feb. 2007, 71(2):214 - 219 - Aprataxin (APTX) gene mutations resembling multiple system atrophy
Yasuhiko Baba; Ryan J. Uitti; Kevin B. Boylan; Yoshinari Uehara; Tatsuo Yamada; Matthew J. Farrer; Elizabeth Couchon; Sat Dev Batish; Zbigniew K. Wszolek
PARKINSONISM & RELATED DISORDERS, 2007, 13(3):139 - 142, Refereed - Positive correlation between chymase-like angiotensin II -forming activity in mononuclear cells and serum cholesterol level
Kinshiro Murakami; Yoshinari Uehara; Satomi Abe; Yukiko Inoue; Munehito Ideishi; Keijiro Saku; Hidenori Urata
Journal of Cardiology, 2007, 50(5):291 - 298, Refereed
Corresponding - 新春対談 メタボリックシンドロームと不整脈の非薬物治療
朔啓二郎; 上原吉就; 安田智生
Vascular Street, 2007, 2(1):1 - 6 - Effects of apoA-Ⅰ/phosphatidylcholine discs on charge-based LDL subfractions as characterized by capillary isotachophoresis.
Zhang B; Uehara Y; Hida S; Miura S; Rainwater D; Segawa M; Kumagai K; Rye K; Saku K
J Lipid Res, 2007, 48:1175 - 1189 - Low-density lipoprotein oxidized to various degrees activates ERK 1/2 through Lox-1
Hiroyuki Tanigawa; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Yoshino Matsuo; Masahiro Fujino; Tatsuya Sawamura; Keijiro Saku
ATHEROSCLEROSIS, Oct. 2006, 188(2):245 - 250, Refereed - ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis
Bo Zhang; Shin-ichiro Miura; Ping Fan; Koichiro Kumagai; Kazuma Takeuchi; Yoshinari Uehara; Monica McMahon; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, Sep. 2006, 188(1):95 - 101, Refereed - PPARαアゴニストとメタボリックシンドローム
上原吉就; 朔 啓二郎
Medical Practice, Sep. 2006, 23(9):1631 - 妊娠高血圧に対し多くのCa拮抗薬は投与禁忌とされているが、最近では使用の有用性が認められてきている？
古山正大; 上原吉就; 朔 啓二郎
薬局, Aug. 2006, 57(8):2633 - 2636 - Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor
Shin-ichiro Miura; Masahiro Fujino; Hiroyuki Hanzawa; Yoshihiro Kiya; Satoshi Imaizumi; Yoshino Matsuo; Sayo Tomita; Yoshinari Uehara; Sadashiva S. Karnik; Hiroaki Yanagisawa; Hiroyuki Koike; Issei Komuro; Keijiro Saku
JOURNAL OF BIOLOGICAL CHEMISTRY, Jul. 2006, 281(28):19288 - 19295, Refereed - アゼルニジピンのLDLに対する抗酸化作用 - キャピラリー電気泳動法による評価
谷川宏之; 三浦 伸一郎; 岡村圭祐; 西川宏明; 上原吉就; 張 波; 朔 啓二郎
Progress in Medicine, Jul. 2006, 26(7):1661 - 1664, Refereed - Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration
B Zhang; P Fan; E Shimoji; H Itabe; S Miura; Y Uehara; A Matsunaga; K Saku
ATHEROSCLEROSIS, Jun. 2006, 186(2):291 - 301, Refereed - 妊娠を希望する高血圧の女性への降圧薬はどうすればよいのか
上原吉就; 朔 啓二郎
治療, Apr. 2006, 88(4):1335 - 1340 - 善玉コレステロールが高すぎるのも身体に害になるのか？
上原吉就; 朔 啓二郎
治療 増刊号, Mar. 2006, 88:875 - 879 - 脂質代謝異常症における遺伝子診療
上原吉就; 朔 啓二郎
循環器科, Mar. 2006, 60(3):213 - 217 - コレステロール輸送とABCトランスポーター
上原吉就; 朔 啓二郎
Medical Practice, Jan. 2006, 23(1):152 - 南区Life Style Careフォーラム
松永彰; 上原吉就; 安田智生; 朔啓二郎
Vascular Street, 2006, 1(10):1 - 6 - Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction
K Noda; B Zhang; Y Uehara; S Miura; A Matsunaga; K Saku
CIRCULATION JOURNAL, Dec. 2005, 69(12):1568 - 1570, Refereed - HDL治療
三浦伸一郎; 上原吉就; 朔 啓二郎
治療, Jul. 2004, 86(7):2172 - 2175 - 増えつつある高脂血症とリスク - 低HDLコレステロール血症
上原吉就; 朔 啓二郎
臨牀と研究, Jun. 2004, 81(6):965 - 970 - 追加療法で心不全が劇的に改善した拡張型心筋症の一例
高宮陽介; 三浦伸一郎; 森憲; 上原吉就; 西川宏明; 白井和之; 松尾邦浩; 福田圭介; 松永彰; 朔啓二郎
臨床と研究, Jun. 2004, 81(6):165 - 169 - 低ＨＤＬ血症
上原吉就; 朔啓二郎
循環器医が治療する糖尿病と大血管障害, 2004, :105 - 108 - The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux - Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo
A Chroni; T Liu; Gorshkova, I; HY Kan; Y Uehara; A von Eckardstein; Zannis, VI
JOURNAL OF BIOLOGICAL CHEMISTRY, Feb. 2003, 278(9):6719 - 6730, Refereed - Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1
Y Uehara; T Engel; ZC Li; C Goepfert; S Rust; XQ Zhou; C Langer; C Schachtrup; J Wiekowski; S Lorkowski; G Assmann; A von Eckardstein
DIABETES, Oct. 2002, 51(10):2922 - 2928, Refereed
Lead - Testosterone up-regulates scavenger receptor B1 and stimulates cholesterol efflux from macrophages
C Langer; B Gansz; C Goepfert; T Engel; Y Uehara; G von Dehn; H Jansen; G Assmann; A von Eckardstein
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Sep. 2002, 296(5):1051 - 1057, Refereed - Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta
Yoshinari Uehara; Hidenori Urata; Munehito Ideishi; Kikuo Arakawa; Keijiro Saku
Cardiovascular Research, 2002, 55(4):870 - 876, Refereed
Lead - ABCA1と細胞内コレステロール代謝
上原吉就; Arnold von Eckardstein
循環器科, May 2001, 50(5):406 - 411 - 慢性心不全－病態 神経体液因子 レニン－アンジオテンシン－アルドステロン系
上原吉就; 浦田秀則
カレントテラピー, Jun. 2000, 18(6):38 - 42 - Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia
Y Uehara; H Urata; M Sasaguri; M Ideishi; N Sakata; T Tashiro; M Kimura; K Arakawa
HYPERTENSION, Jan. 2000, 35(1):55 - 60, Refereed
Lead - 米国心臓病学会学術集会の紹介
張波; 熊谷浩一郎; 中島英子; 上原吉就; 古賀敬史; 星野史博; 浦田秀則; 朔啓二郎
内科専門医会誌, 2000, 12(2):188 - 193 - 血管外膜とキマーゼ
上原吉就; 浦田秀則
血管と内皮, Mar. 1999, 9(3):268 - 274 - Genetic analysis of the epithelial sodium channel in Liddle's syndrome
Y Uehara; M Sasaguri; A Kinoshita; E Tsuji; H Kiyose; H Taniguchi; K Noda; M Ideishi; J Inoue; K Tomita; K Arakawa
JOURNAL OF HYPERTENSION, Aug. 1998, 16(8):1131 - 1135, Refereed - 上皮型Naチャンネル遺伝子の点変異（Pro616→Ser）を確認し得たLiddle症候群の一同胞例
上原吉就; 清瀬はるな; 谷口晴美; 木下昭生; 野田慶太; 笹栗 学; 出石宗仁; 井上準之助; 冨田公夫; 荒川規矩男
ホルモンと臨床, Jul. 1998, 46(夏季増刊):160 - 164, Refereed - 高血圧症-治療研究の進歩-非薬物療法
上原吉就; 荒川規矩男
日本臨床, Aug. 1997, 55(8):152 - 156
Lead - Liddle症候群の一例
上原吉就; 信国寿美重; 木下昭生; 笹栗 学; 出石宗仁; 荒川規矩男
ホルモンと臨床, Dec. 1996, 44(冬季増刊):211 - 214, Refereed
- 総合大学の教養科目としての多職種連携教育
安元 佐和; 八尋 英二; 武岡 宏明; 竹井 亜里; 石山 由樹; 宮城 由美子; 大田 博; 三島 健一; 松末 公彦; 江川 孝; 檜垣 靖樹; 上原 吉就; 道下 竜馬
保健医療福祉連携, Mar. 2024, 17(1):72 - 73 - ケトン体がミトコンドリアならびに細胞内脂質輸送へおよぼす作用の検討
上原, 吉就
福岡大学研究部論集 F：推奨研究編, Dec. 2023, 11:1 - 11 - 沖縄の薬草と健康長寿 キューバ産サトウキビ由来ポリコサノールの脂質改善と長寿因子HDLの向上作用
上原 吉就
機能性食品と薬理栄養, Dec. 2023, 17(3):152 - 152 - 今年も開催!!行列のできる診療所第3弾:脂質異常症難病ケーススタディ IgG4関連LCAT自己抗体による後天性LCAT欠損症の一例
小松 知広; 西田 尚史; 遠藤 康弘; 荒川 純子; 寺本 麻菜美; 阿部 智美; 山本 泰暉; 桂田 由佳; 宮下 かずや; 佐々木 誠; 三宅 隆之; 桜田 真己; 松熊 晋; 上原 吉就; 池脇 克則
日本動脈硬化学会総会プログラム・抄録集, Jun. 2023, 55回:131 - 131 - 乳酸閾値での間欠的運動は、継続的運動と比較して身体的ストレスを抑制するが、成長ホルモンは増加させない
山本 泰暉; 田上 友季也; 檜垣 靖樹; 上原 吉就; 田中 宏暁; 楢崎 兼司
健康支援, Feb. 2023, 25(1):67 - 67 - 阻害薬非感受性NCX1変異体ノックインマウスを用いた薬効評価系の構築
篠田 康晴; 喜多 知; 根本 隆行; 小松 知広; 上原 吉就; 喜多 紗斗美; 岩本 隆宏
血管, Jan. 2023, 46(1):53 - 53 - 人工HDLによる骨格筋筋芽細胞のミトコンドリア機能への影響
小松 知広; 中島 志穂子; 阿部 智美; 佐々木 慧; 岩本 隆宏; 上原 吉就
血管, Jan. 2023, 46(1):62 - 62 - One healthから考える老化予防に向けたバイオマーカー探索 人工甘味料の骨格筋への作用とアスリートへの影響
上原 吉就
機能性食品と薬理栄養, Dec. 2022, 16(3):124 - 124 - アポリポ蛋白A1ペプチドは骨格筋筋芽細胞のミトコンドリア機能を促進する
小松 知広; 中島 志穂子; 阿部 智美; 佐々木 慧; 岩本 隆宏; 上原 吉就
マグネシウム, Nov. 2022, 41(1):44 - 45 - 【基礎研究を心臓リハビリテーションのエビデンスに活かす】運動が脳パフォーマンスへおよぼす影響
上原 吉就; 田上 友季也
心臓リハビリテーション, Nov. 2022, 28(3-4):248 - 252 - パーキンソン病患者に対する卓球リハビリテーション療法の有効性および安全性の検討
井上 賢一; 藤岡 伸助; 長城 晃一; 末永 みどり; 木村 一喜; 米倉 有希子; 山口 良樹; 北野 晃祐; 今村 律子; 上原 吉就; 菊池 仁志; 松永 洋一; 坪井 義夫
臨床神経学, Sep. 2021, 61(Suppl.):S340 - S340 - 要支援高齢者の日常身体活動量と身体組成
園田 剛之; 高江 理恵; 畑本 陽一; 安方 惇; 上原 吉就; 檜垣 靖樹; 藤田 真里; 田中 宏暁
理学療法学, Aug. 2019, 46(Suppl.1):P - 004 - 人工HDLの中性脂肪へおよぼす影響の検討
上原 吉就; 朔 啓二郎; 浦田 秀則; 小川 正浩; 鍋島 茂樹
福岡大学研究部論集, Dec. 2018, 6(1):39 - 43 - CKDstage2患者の腎血流量は運動強度に依存して低下する
神徳和子; 神徳和子; 安野哲彦; 川上翔太郎; 釘本郁美; 後藤里奈; 中川洋成; 中島志穂子; 中島志穂子; 小見山高明; 高江理恵; 松田拓朗; 藤見幹太; 上原吉就; 上原吉就; 田中宏暁; 田中宏暁; 檜垣靖樹; 檜垣靖樹
日本腎臓リハビリテーション学会学術集会プログラム・抄録集, 2018, 8th - 生活期脳卒中に肘HAL-SJを導入した在宅支援プログラムの予備的研究
百武 光一; 上原 吉就; 森下 登史; 齊田 和哉; 井上 亨
日本作業療法学会抄録集, Sep. 2017, 51回:OA - 2 - Exercise Training Rescues High Fat Diet-induced Neuronal Nitric Oxide Synthase Expression In Hippocampus And Cortex.
Yuki Tomiga; Saki Yoshimura; Ai Ito; Kentaro Kawanaka; Yoshinari Uehara; Hiroaki Tanaka; Yasuki Higaki
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, May 2017, 49(5):306 - 307 - Effects Of Aerobic And Resistance Exercise On Cognitive Function.
Takaaki Komiyama; Kenji Ando; Mizuki Sudo; Ryuji Takigawa; Kazunori Ohkawara; Yoshinari Uehara; Hiroaki Tanaka; Yasuki Higaki; Soichi Ando
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, May 2017, 49(5):698 - 698 - Inhibition of lipopolysaccharide induced gene expression by HDL from healthy subjects and patients with acute myocardial infarction
S. Imaizumi; K. Takata; E. Yahiro; E. Kawachi; A. Iwata; Y. Uehara; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2016, 37:217 - 218 - LCZ696, the angiotensin-receptor neprilysin inhibitor, attenuates cardiac fibrosis and improves its function in the heart failure model of diabetes mellitus in mice
Y. Suematsu; S. Miura; M. Goto; E. Yahiro; Y. Uehara; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2015, 36:661 - 661 - Angiotensin II Receptor-Neprilysin Inhibitor, LCZ696 Blocked Aldosterone Synthesis in Human Adrenocortical Cell Line
S. Miura; Y. Suematsu; Y. Matsuo; S. Tomita; A. Nakayama; M. Goto; E. Yahiro; Y. Uehara; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2015, 36:662 - 662 - Exercise Training Rescues High Fat Diet-induced Neuronal Nitric Oxide Synthase Expression In Hippocampus And Cortex
Yuki Tomiga; Saki Yoshimura; Ai Ito; Kentaro Kawanaka; Yoshinari Uehara; Hiroaki Tanaka; Yasuki Higaki
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, May 2015, 47(5):306 - 307 - 新規動脈硬化分子イメージングの開発
朔 啓二郎; 上原 吉就; 三浦 伸一郎; 小川 正浩
福岡大学研究部論集. F, 推奨研究編 : 推奨研究プロジェクト成果報告書 = The bulletin of Central Research Institute Fukuoka University, Mar. 2015, 2:57 - 64 - A newly developed apoA-I mimetic peptide with a D-amino acid promotes HDL via ABCA1-mediated cholesterol efflux
E. Kawachi; Y. Uehara; E. Yahiro; S. Abe; S. Ando; S. I. Miura; K. Saku
EUROPEAN HEART JOURNAL, Sep. 2014, 35:1123 - 1123 - Impact of smoking habit on coronary plaque vulnerability as assessed by integrated backscatter intravascular ultrasound
A. Iwata; Y. Uehara; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Sep. 2014, 35:901 - 902 - Effect of smoking cessation on HDL function
E. Kawachi; S. Imaizumi; K. Takata; S. Abe; Y. Matsuo; E. Yahiro; Y. Uehara; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Sep. 2014, 35:902 - 902 - 臨床研究に向けた68Ga-DOTA-FAMP調製法の最適化
長谷川功紀; 上原吉就; 川内絵未; 吉田毅; 矢野恒夫; 三浦伸一郎; 朔啓二郎
核医学, Sep. 2014, 51(3):276 - 276 - An inducible Cholesterol Efflux (iCeE) peptide-famp is taken up by the intracellular atherosclerotic plaque burden
E. Yahiro; Y. Uehara; E. Kawachi; K. Hasegawa; T. Yano; Y. Watanabe; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2013, 34:179 - 179 - HDL Functionality Could be a Novel Marker for Predicting Restenosis after Stent Implantation
Satoshi Imaizumi; Shin-Ichiro Miura; Yosuke Takamiya; Akira Kawamura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Kunihiro Matsuo; Kazuyuki Shirai; Yoshinari Uehara; Srinivasa T. Reddy; Keijiro Saku
CIRCULATION, Nov. 2012, 126(21) - Synthesis of ^<68>Ga-DOTA-FAMP and PET Imaging Study with Atherosclerotic Plaques
HASEGAWA Koki; KAWACHI Emi; KUWABARA Ren; YAHIRO Eiji; ANDO Setsuko; ONIKI Kousuke; ADACHI Ryuta; WADA Yasuhiro; YANO Tsuneo; UEHARA Yoshinari; MIURA Shin-ichiro; SAKU Keijiro; WATANABE Yasuyoshi
Peptide science : proceedings of the ... Japanese Peptide Symposium, 01 Mar. 2012, 2011:291 - 294 - 福岡大学発の新規アポA-I模倣ペプチド（FAMP）の開発 〜 動脈硬化治療薬および動脈硬化診断薬としての可能性 〜
上原 吉就; 八尋 英二; 三浦 伸一郎; 安東 勢津子; 朔 啓二郎
Research, Mar. 2012, 17(1):29 - 30 - Correlation of Structure in Solution and Lipid Affinity of ApolipoproteinA-I Mimetic Peptide (II)
Ryuta Adachi; Kousuke Oniki; Haruhiko Aoyagi; Satomi Abe; Yoshinari Uehara; Keijiro Saku; Keiichi Yamada; Setsuko Ando
Peptide Science 2011, 2012, :237 - 240 - A Randomized, Double-blind, Controlled, Comparative Trial of Formula Food Containing Soy Protein versus Milk Protein in Visceral Fat Obesity: FLAVO study
Yoshinari Uehara; Takahira Masaya; Keita Noda; Bo Zhang; Ryoko Mitsutake; Masahiro Ogawa; Tatsuyuki Kakuma; Keijiro Saku
CIRCULATION, Nov. 2011, 124(21) - Effects of Rosuvastatin and Atorvastatin on Macrophage Reverse Cholesterol Transport in Vivo
Tomohiko Shimizu; Hiroyuki Tanigawa; Shin-ichiro Miura; Yoshinari Uehara; Bo Zhang; Keijiro Saku
CIRCULATION, Nov. 2011, 124(21) - CORRELATION BETWEEN LDL-LOWERING BY STATINS AND HEMORHEOLOGICAL PROFILES: A SUBSTUDY OF THE PATROL TRIAL
K. Saku; B. Zhang; Y. Uehara; K. Noda
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2011, 12(1):168 - 168 - 合成脂質とリポ蛋白研究チーム － 合成脂質のリポ蛋白新生作用を介した神経障害および動脈硬化進展への抑制作用の検討
上原吉就; 馬場康彦; 山田達夫; 井上展聡
Research, Mar. 2011, 16(1):38 - 42 - 「酸化ストレスマーカーの診療への応用」 HDL治療の開発：コレステロール輸送体とアポA-1模倣ペプチドを標的とした創薬開発
朔啓二郎; 上原吉就; 三浦伸一郎; 張波; 野田慶太; 西川宏明; 小川正浩; 河村彰; 北島研; 岩田敦; 細井薫; 出石宗仁
ワンキャンパスプロジェクト テーマ⑥ 「バイオストレス応答の制御機構研究教育拠点」 2010年度 研究成果報告書, Mar. 2011, :81 - 86 - Synthesis of a new apoA-I mimetic peptide inducing the dissociation of lipid-poor apoA-I from plasma HDL
Oniki K; Adachi R; Abe S; Uehara Y; Saku K; Shioi S; Ando S
Peptide Science, 2011, :245 - 246 - 3. 循環器・代謝疾患分子標的グループ
朔啓二郎; 三浦伸一郎; 瀬川波子; 上原吉就; 西川宏明; 小川正浩; 河村彰
先端分子医学研究センター 2010年度年報, 2011, :121 - 179 - 「酸化ストレスマーカーの診療への応用」 HDL治療の開発：コレステロール輸送体とアポA-1模倣ペプチドを標的とした創薬開発
朔啓二郎; 上原吉就; 三浦伸一郎; 張波; 野田慶太; 西川宏明; 小川正浩; 河村彰; 北島研; 岩田敦; 細井薫; 出石宗仁
私立大学戦略的研究基盤形成支援事業 身体活動の研究拠点形成, 2011, :107 - 111 - FAMP, a Novel Apo A-I Mimetic Peptide, Promotes Macrophage Reverse Cholesterol Transport in vivo
Hiroyuki Tanigawa; Shin-ichiro Miura; Yoshinari Uehara; Keijiro Saku
CIRCULATION, Nov. 2010, 122(21) - FAMP, A Powerful Producer of Pre-Beta HDL via an ABCA1-Mediated Cholesterol Efflux Pathway
Yoshinari Uehara; Setsuko Ando; Kosuke Oniki; Eiji Yahiro; Hiroyuki Tanigawa; Shin-ichiro Miura; Keijiro Saku
CIRCULATION, Nov. 2010, 122(21) - 冠動脈形成術が成功した患者におけるARBのPigment Epithelium-derived Factorに対する効果
杉原 充; 三浦 伸一郎; 上原 吉就; 山岸 昌一; 朔 啓二郎
日本高血圧学会総会プログラム・抄録集, Oct. 2010, 33回:406 - 406 - A RANDOMIZED OPEN TRIAL OF VARENICLINE VERSUS NICOTINE PATCH IN ADULT SMOKERS: EFFICACY, SAFETY AND WITHDRAWAL SYMPTOMS (THE VN-SEESAW STUDY)
H. Tsukahara; K. Noda; Y. Uehara; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2010, 11(2):151 - 151 - What kinds of patients should undergo coronary computed tomography as screening for coronary artery disease?
Shin-ichiro Miura; Ryoko Mitsutake; Yuhei Shiga; Yoshinari Uehara; Keijiro Saku
ENDOCRINE JOURNAL, Mar. 2010, 57:S556 - S557 - Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by mdct in patients with suspected coronary artery disease
Shin-ichiro Miura; Ryoko Mitsutake; Yuhei Shiga; Yoshinari Uehara; Keijiro Saku
ENDOCRINE JOURNAL, Mar. 2010, 57:S557 - S557 - SYNTHESIS OF A PEPTIDE REMOVING CHOLEATEROL FROM CELL AND ITS ABILITY OF HDL FORMATION IN BLOOD PLASMA
Kousuke Oniki; Setsuko Ando; Yoshinari Uehara; Bo Zhang; Keijiro Saku
Peptide Science.2009, 2010, :281 - 284 - Famp, a Novel Apoa-I Mimetic Peptide Promotes Hdl Via Abca1-Dependen Cholesterol Efflux.
Uehara Y; Ando S; Oniki K; Abe S; Yahiro E; Tanigawa H; Miura SI; Saku K
Atherosclerosis Supplements 2010, 2010, 11:3 - 3 - The Effects of Statin and Lipoprotein Metabolism in Heart Failure
Shin-Ichiro Miura; Natsumi Morito; Yoshinari Uehara; Keijiro Saku
JOURNAL OF CARDIAC FAILURE, Sep. 2009, 15(7):S142 - S142 - PE-400 HDL-Raising Efficacy and the Effects of ROSuvastatin on Small, Dense Electronegative LDL as Characterized by CapillARY Isotachophoresis : The ROSARY Study(PE067,Lipid Disorders 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Matsunaga Akira; Miura Shinichiro; Noda Keita; Nishikawa Hiroaki; Uehara Yoshinari; Shirai Kazuyuki; Ogawa Masahiro; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2009, 73:500 - 501 - Analysis of short isoforms of ABCG4 lipid transporter
Yoshinari Uehara; Satomi Abe; Takuya Iyoda; Satomi Kita; Keijiro Saku; Takahiro Iwamoto
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109:65P - 65P - Enhanced Angiotensin II Forming Activity In Mononuclear Cell By Elevated Free Fatty Acid: Possible Implication in Endothelial Dysfunction as Mobile Renin-Angiotensin System
Shinichiro Ueda; Yoko Azekoshi; Takanori Yasu; Ken Yamakawa; Tomomi Abe; Yoshinari Uehara; Hidenori Urata
CIRCULATION, Oct. 2008, 118(18):S365 - S366 - ATP-binding cassette transporter G1 promoter variant influences to a severity of coronary artery disease
Y. Uehara; S. Furuyama; S. Abe; S. I. Miura; B. Zhang; K. Saku
CIRCULATION, Sep. 2008, 118(12):E199 - E199 - High chymase activity in the circulating mononuclear leukocyte is related to high c-reactive protein and insulin levels
K. Okamura; Y. Inoue; Y. Uehara; S. Sumi; K. Kudou; S. Kodama; C. Andou; H. Mihara; H. Niimura; M. Miyoshi; Y. Tsuchiya; S. Miura; Y. Yamanouchi; K. Saku; H. Urata
JOURNAL OF HYPERTENSION, Jun. 2008, 26:S317 - S318 - A SEVERITY OF CORONARY ARTERY DISEASE IS INFLUENCED BY ABCG1-257T > G PROMOTER POLYMORPHISM IN JAPANESE MEN
Y. Uehara; S. Furuyama; S. Abe; S. Miura; B. Zhang; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, May 2008, 9(1):23 - 23 - コレステロール輸送体を標的とした新たな動脈硬化症・認知症治療の開発
上原吉就
福岡大学研究シーズ集2008, Apr. 2008, :65 - PE-405 Effect of Pioglitazone on Lipid Profiles as Assessed by Analytical Capillary Isotachophores is in Patients with Type 2 Diabetes(Diabetes/Obesity/Metabolic syndrome(07)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Uehara Yoshinari; Zhang Bo; Miura Shinichiro; Kawamura Akira; Iwamoto Takahiro; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2008, 72:461 - 461 - PJ-040 Apolipoprotein E interrupts NF-κB signaling by binding to IRAK-1 via LRP1 in vascular smooth muscle cells(Atherosclerosis, basic(05)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Kawamura Akira; Miura Shinichiro; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2008, 72:520 - 520 - PJ-520 Molecular basis of the antagonistic action of AT2 receptor on AT1 receptor signaling(Hypertension, basic(04)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Matsuo Yoshino; Miura Shinichiro; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2008, 72:643 - 643 - OE-206 PPAR-α Agonist (R)-K-13675 Inhibits the Secretion of Inflammatory Markers from Human Coronary Artery Endothelial Cells Without Affecting Proliferation or Angiogenesis(Lipid disorders(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Kitajima Ken; Miura Shinichiro; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2008, 72:232 - 232 - OE-230 Adiponectin and its Receptors Increase Cholesterol Efflux in HEK293T Cells(Metabolism/Biochemistry/Energetics(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Kitajima Ken; Miura Shinichiro; Yamauchi Toshimasa; Uehara Yoshinari; Kadowaki Takashi; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2008, 72:238 - 238 - Enhanced cholesterol efflux with adiponectin and its receptors in HEK293T cells
Ken Kitajima; Shin-Ichiro Miura; Toshimasa Yamauchi; Yoshinari Uehara; Takashi Kadowaki; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Mar. 2008, 51(10):A320 - A321 - ATP-binding cassette transporter G1 promoter-257T > G polymorphism provides a characterization of high-density lipoprotein
Keisuke Okamura; Yoshinari Uehara; Bo Zhang; Shin-ichiro Miura; Hidenori Urata; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Mar. 2008, 51(10):A323 - A323 - 高比重リポ蛋白（HDL)治療の確立
上原吉就; 瀬川波子; 松尾邦浩; 西川宏明; 三浦伸一郎; 朔啓二郎
Research, Mar. 2008, 13(1):31 - 33 - ABCG1・G4遺伝子の脳内コレステロール調節メカニズムの解明およびアルツハイマー病との関連性
上原吉就
臨床研究奨励基金, Mar. 2008, (21):2 - 6 - Roles of ABCG4 cholesterol transporter in Alzheimer's disease
Yoshinari Uehara; Satomi Abe; Masa-aki Higuchi; Tatsuo Yamada; Takahiro Iwamoto
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106:115P - 115P - Newly developed PPAR-alpha agonist (R)-K-13675 inhibits the secretion inflammatory markers from human coronary artery endothelial cells
Ken Kitajima; Shin-Ichiro Miura; Yoshinari Uehara; Keijiro Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, Jun. 2007, 27(6):E70 - E70 - Adiponectin and its receptors increased cholesterol efflux in HEK293T cells
Ken Kitajima; Shin-ichiro Miura; Toshimasa Yamauchi; Yoshinari Uehara; Takashi Kadowaki; Keijiro Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, Jun. 2007, 27(6):E103 - E103 - 1)発作性心房細動患者におけるplatelet-activating factor acetylhydrolaseの炎症性マーカーとしての意義(第101回日本循環器学会九州地方会)
岡村 圭祐; 三浦 伸一郎; 張 波; 上原 吉就; 熊谷 浩一郎; 朔 啓二郎
Circulation journal : official journal of the Japanese Circulation Society, 20 Apr. 2007, 71:888 - 888 - OE-041 ATP-binding Cassette Transporter G1 Promoter Polymorphism Relates to Modify a Character of High-density Lipoprotein Cholesterol(Atherosclerosis, clinical-01, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Okamura Keisuke; Uehara Yoshinari; Furuyama Shodai; Abe Satomi; Zhang Bo; Miura Shinichiro; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:161 - 161 - PJ-516 Apolipoprotein A5 Gene Polymorphisms, -1131T>C and c.553G>T were in Strong Linkage Disequilibria and Associated with Hypertriglyceridemia in Japanese(Lipid disorders-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Matsunaga Akira; Arishima Hiroaki; Niimura Hideya; Zhang Bo; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:601 - 601 - OE-074 Apolipoprotein E Inhibits NF-κ B Activation by Binding to Interleukin Receptor Associated Kinase-1(Atherosclerosis, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Kawamura Akira; Miura Shinichiro; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:170 - 170 - PE-173 Effects for Metabolic Factors by Reconstituted High-density Lipoprotein in Goto-Kakizaki Rats(Metabolism/Biochemistry/Energetics-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Kiya Yoshihiro; Miura Shin-ichiro; Imaizumi Satoshi; Uehara Yoshinari; Rye Kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:368 - 368 - OE-283 ApoA-I/Phosphatidylcholine Discs Reduce Charge-Modified LDL as Characterized by Capillary Isotachophoresis(Lipid disorders-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Uehara Yoshinari; Hida Satoru; Miura Shin-ichiro; Kumagai Koichiro; Rye Kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:221 - 221 - PJ-715 Apolipoprotein E interrupts Interlrukin-1 β signaling upstream of Activating Protein-1 and c-Jun in Vascular Smooth Muscle Cells(Vascular smooth muscle-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Kawamura Akira; Miura Shinichiro; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:650 - 650 - PE-250 Reconstituted-HDL Has a Potential for Anti-atherogenic Lipoprotein Modulator(Lipid disorders-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Uehara Yoshinari; Zhang Bo; Abe Satomi; Miura Shinichiro; Furuyama Shodai; Yamada Tatsuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:387 - 387 - PE-205 Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Suppresses a Fast-migarating LDL by Capillary Isotachophoresis(Atherosclerosis, clinical-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Uehara Yoshinari; Zhang Bo; Miura Shinichiro; Furuyama Shoudai; Okamura Keisuke; Yamada Tatsuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007, 71:376 - 376 - Angiotensin II forming-activities in the human mononuclear cell fraction isolated from the peripheral blood
Satomi Abe; Yukiko Inoue; Yoko Tagomori; Aki Ohtani; Harumi Ide; Yoshinari Uehara; Keijiro Saku; Hidenori Urata
JOURNAL OF HYPERTENSION, Dec. 2006, 24:86 - 86 - Peiotropic action of HDL and HDL therapy
S. Miura; Y. Kiya; S. Imaizumi; B. Zhang; Y. Matsuo; Y. Uehara; K. A. Rye; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006, 7(3):561 - 561 - Apolipoprotein A5 gene polymorphisms, -1131T > C and c.553G > T were in strong linkage disequilibria and associated with hypertriglyceridemia in Japanese
A. Matsunaga; H. Arishima; Y. Uehara; B. Zhang; H. Niimura; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006, 7(3):396 - 396 - Effects of pitavastatin for expression of the apolipoprotein A5 in HepG2 cell
A. Matsunaga; H. Arishima; Y. Uehara; B. Zhang; H. Niimura; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006, 7(3):570 - 571 - Pharmacological intervention using reconstituted high-density lipoprotein changes the lipid profile in spontaneously hypersensitive rats
S. Imaizumi; S. Miura; Y. Kiya; B. Zhang; Y. Uehara; K. A. Rye; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006, 7(3):562 - 562 - PJ-067 What is the Pharmacotherapeutic Relevance of Inverse Agonism (IA) toward Angiotensin II Type 1 (AT1) Receptor in Dahl Rat?(Hypertension, basic-4 (H) PJ12,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Kiya Yoshihiro; Miura Shinichiro; Imaizumi Satoshi; Tomita Sayo; Matsuo Yoshino; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2006, 70:506 - 506 - PJ-242 Pitavastatin Upregulates the Expression of the Apolipoprotein A5 in HepG2 Cell(Lipid disorders-3 (H) PJ41,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Arishima Hiroaki; Matsunaga Akira; Niimura Hideya; Zhang Bo; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2006, 70:549 - 550 - PJ-245 Pharmacological Intervention Using Reconstituted High-density Lipoprotein (rHDL) Changes the Lipid Profile in Spontaneously Hypersensitive Rats (SHR)(Lipid disorders-3 (H) PJ41,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Imaizumi Satoshi; Miura Shinichiro; Kiya Yoshihiro; Zhang Bo; Uehara Yoshinari; Rye Kerry-Ann; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2006, 70:550 - 550 - Apolipoprotein A-I discs may prevent apoptosis through ERK activation in myocytes
Y Kiya; S Miura; S Imaizumi; Y Uehara; Y Matsuo; H Urata; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005, 39(6):1012 - 1012 - Apolipoprotein A-I discs containing sphingosine-1-phosphate induced coronary artery endothelial tube formation through Akt/ERK/NO pathway
Y Matsuo; S Miura; Y Kiya; S Imaizumi; Y Uehara; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005, 39(6):1004 - 1004 - Apolipoprotein A-I discs-induced nitric oxide production in coronary endothelial cells may suppress reperfusion-induced arrhythmias in rats
S Imaizumi; S Miura; Y Uehara; Y Kiya; H Urata; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005, 39(6):1001 - 1002 - ApoA-I discs prevent pathological remodeling after myocardial infarction in rats
Y Kiya; S Miura; S Imaizumi; Y Uehara; KA Rye; K Saku
CIRCULATION, Oct. 2005, 112(17):U343 - U343 - Platelet-activating factor-acetylhydrolase fraction may be a useful new marker for coronary restenosis as well as vasospasm
K Okamura; S Miura; B Zhang; Y Uehara; H Nishikawa; K Shirai; K Matsuo; K Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, May 2005, 25(5):E97 - E97 - Platelet-activating factor-acetylhydrolase may be a therapeutic target for preventing atrial fibrillation
K Okamura; Miura, I; Y Uehara; K Matsuo; B Zhang; K Kumagai; K Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, May 2005, 25(5):E97 - E97 - The ATP-binding Cassette Transporter A1 and G1 are Suppressed by Unsaturated Fatty Acids via Inactivation of LXR/RXR Responsible Element(Diabetes/Obesity 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Uehara Yoshinari; Miura Shinichrou; Fujii Akihiro; Yamada Tatsuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2005, 69:222 - 222 - Reperfusion-induced Aarrhythmias are Suppressed by Reconstituted High-density Lipoprotein in Rats(Arrhythmia, Basic 4 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Imaizumi Satoshi; Uehara Yoshinari; Miura Shin-ichiro; Kiya Yoshihiro; Kumagai Koichiro; matuo yoshino; abe tomomi; McMahon M; Ideishi Munehito; urata hidenori; Rye kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2005, 69:274 - 274 - Reconstituted High-density Lipoprotein Containing Sphingosine-1-phosphate Induces Cholesterol Efflux as well as Endothelial Tube Formation(Endothelium/NO 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Kiya Yoshihiro; Miura Shin-ichiro; Imaizumi Satoshi; Uehara Yoshinari; matuo yoshino; Rye Kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2005, 69:296 - 297 - HDL治療 (特集 プライマリケア医のための循環器疾患診療--診断技法と治療法のパラダイムシフト)
三浦 伸一郎; 上原 吉就; 朔 啓二郎
治療, Jul. 2004, 86(7):2172 - 2175 - Azelnidipine indirectly induces coronary endothelial tube formation through PKC by increasing the secretion of vascular endothelial growth factor from smooth muscle cells
S Miura; H Tanigawa; M Fujino; Y Matsuo; K Okamura; Y Uehara; K Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, May 2004, 24(5):E11 - E12 - Chymase inhibitor suppresses aortic lipid accumulation in cholesterol-fed hamster
Y Uehara; H Urata; M Ideishi; K Saku; K Arakawa
JOURNAL OF HYPERTENSION, 2000, 18:S92 - S92 - Aortic chymase activity is up-regulated in cholesterol fed hamster
Y Uehara; H Urata; M Ideishi; K Saku; K Arakawa
JOURNAL OF HYPERTENSION, 2000, 18:S97 - S97 - 高血圧ー治療研究の進歩ー非薬物療法
上原吉就
日本臨牀, 1997, 55:2034 - 2038
- 欧州心臓病学会 (ESC) 心血管薬物療法ハンドブック 日本語翻訳版
小松知広; 上原吉就, Others
OXFORD UNIVERSITY PRESS, 01 Jun. 2020 - 当直医 パニックマニュアル 第2版
松尾邦浩; 鍋島茂樹; 馬場康彦; 西川宏明; 上原吉就 ほか, Others, 50-54
海馬書房, 10 Mar. 2015 - 循環器内科 研修ポケットブック
朔啓二郎; 三浦伸一郎; 今泉聡; 岩田敦; 上原吉就; 小川正浩; 河村彰; 佐光英人; 杉原充; 西川宏明; 藤見幹太; 安田智生, Joint editor, 133-155
福岡大学 医学部 心臓・血管内科学，福岡印刷, May 2014 - 当直医 パニックマニュアル
松尾邦浩; 鍋島茂樹; 馬場康彦; 西川宏明; 上原吉就 ほか, Joint work, 50-54
海馬書房, Nov. 2010 - 新・心臓病診療プラクティス 心血管イベントのリスクファクターとその管理
上原吉就; 朔 啓二郎, Joint work, 181-187
文光堂, Sep. 2009 - 循環器医が治療する糖尿病と大血管障害 V.糖尿病における動脈硬化進展機序 ８.低 HDL 血症
上原吉就; 朔 啓二郎, Joint work, 104-108
メジカルビュー社, Sep. 2004
- HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
Hang Zhang; Tomohiro Komatsu; Shihoko Nakashima; Satomi Abe; Emi Kawachi; Satoshi Imaizumi; Keijiro Saku; Yoshinari Uehara
27th Annual Scientific Meeting of the ISCP, held in Bucharest 27-29 October 2022., 27 Oct. 2022 - 対面から遠隔形式へと移行した大学体育授業が初年次学生の大学適応度・社会的スキルに及ぼす影響の検討
YAMAMOTO Taiki; Ito Sho; UEHARA Yoshinari
日本スポーツ教育学会第41回大会, 29 Oct. 2021, 日本スポーツ教育学会 - 糖尿病治療薬シタグリプチンは、ヒト単球由来マクロファージのcholesterol effluxを促進する
小松知広; 阿部智美; 中島志穂子; 上原吉就
第6回日本血管不全学会学術集会・総会, 11 Apr. 2021 - 主観的にこにこペースのジョギングは認知機能を向上させる
田上友季也; 小見山高明; 上原 吉就; 桧垣 靖樹; 田中 宏暁
第72回日本体力医学会大会, 16 Sep. 2017 - 高脂肪食と運動トレーニングの併用が脂肪酸可能に及ぼす経時的な影響
釘本郁美; 吉村咲紀; 冨賀裕貴; 後藤里奈; 高橋佑莉; 中島志穂子; 上原吉就; 田中宏暁; 檜垣靖樹
第72回日本体力医学会大会, 16 Sep. 2017 - 一過性の間欠式スロージョギングは血中アナボリックホルモンを上昇させる
山本泰暉; 楢崎兼司; 畑本陽一; 青柳遼; 田上友季也; 中島志穂子; 上原吉就; 檜垣靖樹; 田中宏暁
第72回日本体力医学会大会, 16 Sep. 2017 - 高比重リポ蛋白(HDL)が骨格筋ミトコンドリア機能へ与える影響
後藤佑介; 中島志穂子; 阿部智美; 田中宏暁; 檜垣靖樹; 上原吉就
第72回日本体力医学会大会, 16 Sep. 2017 - 高齢者のスロージョギングによる運動介入が身体活動量に及ぼす影響～福岡アイランドシティStudy～
高江理恵; 畑本陽一; 古瀬裕次郎; 小見山高明; 安方惇; 上原吉就; 檜垣靖樹; 田中宏暁
第72回日本体力医学会大会, 16 Sep. 2017 - 高脂肪食と運動の併用における体重の増減に及ぼす効果
釘本郁美; 吉村咲紀; 冨賀裕貴; 中島志穂子; 上原吉就; 田中宏暁; 檜垣靖樹
九州体育・スポーツ学会第66回大会, 25 Aug. 2017 - 高脂肪食摂取及び自発的運動がもたらす肝臓脂肪分布の変化
吉村咲紀; 冨賀裕貴; 釘本郁美; 後藤里奈; 中島志穂子; 田中宏暁; 上原吉就; 檜垣靖樹
九州体育・スポーツ学会第66回大会, 25 Aug. 2017 - 2泊3日の短期減量は体重、身体組成の改善に寄与するか
高江理恵; 畑本陽一; 古瀬裕次郎; 小見山高明; 釘本郁美; 安方惇; 栗山緑; 佐藤紀子; 静間佳代子; 中島志穂子; 上原吉就; 桧垣靖樹; 田中宏暁
第25回西日本肥満研究会, 15 Jul. 2017 - Does cerebral blood flow and oxygenation affect impairment in cognitive function during exercise?
Komiyama T; Tanoue Y; Sudo M; Uehara Y; Tanaka H; Higaki Y; Ando S
The 22th Annual Congress of the European College of Sports Science, 05 Jul. 2017 - Effects of aerobic and resistance exercise on cognitive function
Komiyama T; Ando K; Sudo M; Takigawa R; Ohkahara K; Uehara Y; Tanaka H; Higaki Y; Ando S
The 64nd American College of Sports Medicine Annual Meeting, 30 May 2017 - Exercise training rescues high fat diet-induced neuronal nitric oxide synthase expression in hippocampus and cortex
Tomiga Y; Yoshimura S; Ito A; Kawanaka K; Uehara Y; Tanaka H; Higaki Y
The 64nd American College of Sports Medicine Annual Meeting, 30 May 2017 - Time-course effects of exercise on anxiety-like behaviors and hippocampal neuronal nitric oxide synthase in high fat diet-induced obese mice
Tomiga Y; Yoshimura S; Takahashi Y; Goto R; Kugimoto I; Uehara Y; Kawanaka K; Tanaka H; Higaki Y
Cell symposia Exercise metabolism, 21 May 2017 - 一過性の運動が軽度腎臓機能低下者の腎血流量に及ぼす影響
神徳和子; 安野哲彦; 川上翔太郎; 釘本郁美; 後藤里奈; 中川洋成; 小見山高明; 高江理恵; 中島志穂子; 松田拓朗; 藤見幹太; 上原吉就; 田中宏暁; 桧垣靖樹
第7回日本腎臓リハビリテーション学会学術集会, 19 Feb. 2017 - 高脂肪食と運動トレーニングの併用がグリコーゲン量に及ぼす影響
釘本郁美; 吉村咲紀; 冨賀裕貴; 中島志穂子; 上原吉就; 田中宏暁; 桧垣靖樹
第71回日本体力医学会大会, 23 Sep. 2016 - 高脂肪食誘発性脂肪肝に対する運動の効果
吉村咲紀; 中島志穂子; 冨賀裕貴; 伊藤愛; 川上翔太郎; 田中宏暁; 上原吉就; 桧垣靖樹
第71回日本体力医学会大会, 23 Sep. 2016 - メタボリックシンドローム関連疾患発症における腹囲の検討
田中聖; 道下竜馬; 森戸夏美; 上原吉就; 田中宏暁; 桧垣靖樹
第71回日本体力医学会大会, 23 Sep. 2016 - 高齢者の身体活動量とエネルギーバランスの関係
高江理恵; 畑本陽一; 古瀬裕次郎; 木室ゆかり; 池永昌弘; 安方惇; 静間佳代子; 上原吉就; 桧垣靖樹; 田中宏暁
第71回日本体力医学会大会, 23 Sep. 2016 - 短時間睡眠は運動中及び運動後の認知機能を低下させるか
小宮山高明; 岡崎裕樹; 藤崎勇次; 上原吉就; 田中宏暁; 桧垣靖樹
第71回日本体力医学会大会, 23 Sep. 2016 - 筋萎縮を伴う高齢者の大腿部における各筋容積と形状の特徴
池永昌弘; 渡邊裕也; 山田陽介; 佐藤弘明; 上原吉就; 桧垣靖樹; 田中宏暁
第71回日本体力医学会大会, 23 Sep. 2016 - 腎血流量を減少させない安全な運動強度とは
川上翔太郎; 安野哲彦; 松田拓朗; 藤見幹太; 上原吉就; 田中宏暁; 桧垣靖樹
第6回日本腎臓リハビリテーション学会学術集会, 26 Mar. 2016 - Reduced-dose varenicline is effective for achieving smoking abstinence with fewer adverse effects.
Yoshinari Uehara; Makoto Sugihara; Eiji Yahiro; Natsumi Morito; Hitomi Tsukahara; Keita Noda; Keijiro Saku
15th World Conference on Tobacco or Health, 23 Mar. 2012 - Reduced-dose varenicline is effective use for achieving smoking abstinence with fewer adverse effects
Yoshinari Uehara; Makoto Sugihara; Eiji Yahiro; Natsumi Morito; Hitomi Tsukahara; Keita Noda; Keijiro Saku
The 72st Annual Scientific Meeting of the Japanese Circulation Society, 16 Mar. 2012 - FAMP, A Promising Anti-atherosclerotic Agent Construct Pre-Beta HDL in vitro and in vivo
Y. Uehara; K. Oniki; H. Tanigawa; S. Abe; S. Ando; E. Yahiro; SI. Miura; K. Saku
第43回 日本動脈硬化学会総会, 16 Jul. 2011 - A Novel ApoA-I mimetics, FAMP Constructs Pre-Beta HDL in vitro and in vivo
Y. Uehara; K. Oniki; H. Tanigawa; S. Abe; S. Ando; E. Yahiro; SI. Miura; K. Saku
The 79th European Atherosclerosis Society Congress, 28 Jun. 2011 - 新規可溶型トランスポーター（ABCG4）の同定とアルツハイマー病との関連性
上原吉就; 阿部智美; 馬場康彦; 朔 啓二郎; 山田達夫
第21回日本老年医学会九州地方会, 05 Mar. 2011 - FAMP, A Powerful Producer of Pre-Beta HDL via an ABCA1-Mediated Cholesterol Efflux Pathway
Yoshinari Uehara; S.Ando; K.Oniki; S.Abe; E.Yahiro; H.Tanigawa; SI.Miura; K.Saku
American Heart Association Scientific Sessions 2010, 16 Nov. 2010 - Ca拮抗薬（CCB）／AT1 受容体拮抗薬（ARB）降圧併用療法の家庭血圧・心拍数に対する効果
上原 吉就; 岩田 敦; 森戸 夏美; 八尋 英二; 出石 宗仁; 三浦 伸一郎; 朔 啓二郎
第33回 日本高血圧学会総会, 16 Oct. 2010 - Newly Developed ApoA-I Mimetic Peptides: ABCA1-specific and non-specific peptides
上原吉就; 朔 啓二郎
第42回 日本動脈硬化学会総会, 16 Jul. 2010 - 新規可溶性ATP-binding cassette transporter G4の同定とHDL代謝との関連性
上原吉就; 阿部智美; 馬場康彦; 山田達夫; 岩本隆宏; 朔 啓二郎
第5回トランスポーター研究会年会, 10 Jul. 2010 - IDENTIFICATION AND CLONING OF NOVEL SOLUBLE AND MEMBRANE BOUND FORMS OF HUMAN ATP-BINDING CASSETTE TRANSPORTER G4
Y.Uehara; S.Abe; E.Yahiro; A.Kawamura; T.Iwamoto; SI.Miura; K.Saku
The 78th European Atherosclerosis Society Congress, 22 Jun. 2010 - FAMP, A Novel ApoA-I Mimetic Peptide Promotes HDL via ABCA1-Dependent Cholesterol Efflux
Y.Uehara; S.Ando; K.Oniki; S.Abe; E.Yahiro; H.Tanigawa; SI.Miura; K.Saku
The 78th European Atherosclerosis Society Congress, 21 Jun. 2010 - Identification and Cloning of Novel Soluble and Membrane Bound Forms of The Human ATP-Binding Cassette Transporter G4.
Y.Uehara; S.Abe; E.Yahiro; A.Kawamura; T.Iwamoto; SI.Miura; K.Saku
The 72st Annual Scientific Meeting of the Japanese Circulation Society, 07 Mar. 2010 - FAMP, A Novel ApoA-I Mimetic Peptide Synthesizes HDL via ABCA1 Mediated Pathway
Y.Uehara; S.Ando; K.Oniki; S.Abe; E.Yahiro; H.Tanigawa; SI.Miura; K.Saku
The 72st Annual Scientific Meeting of the Japanese Circulation Society, 05 Mar. 2010 - 高血圧治療の最新の話題
博多区内科医会学術講演会, 08 Dec. 2009 - メタボリックシンドロームにおけるフォーミュラ食の効果
第7回 日本機能性食品医用学会総会, 06 Dec. 2009 - 循環器疾患を合併した糖尿病の治療戦略
延岡アクトスmeeting, 05 Nov. 2009 - 新規アポA-I模倣ペプチドの開発とその効果
第２回福岡心血管リスクフォーラム, 17 Oct. 2009 - スタチンの多面的作用とエビデンス
New Trends in Cardiovascular 2009 -FUKUOKA-, 12 Sep. 2009 - 動脈硬化症とコレステロール：その量と質
博多区内科医会学術講演会, 10 Feb. 2009 - ATP-binding cassette transporter G4 脳特異的アイソフォームの解析
上原吉就; 阿部智美; 伊豫田拓也; 喜多紗斗美; 岩本隆宏
第61回日本薬理学会西南部会, 28 Nov. 2008 - 本態性高血圧患者に対するアゼルニジピンとベニジピンの家庭血圧・心拍数における影響
上原吉就; 藤見幹太; 阿部智美; 三浦伸一郎; 朔 啓二郎
第31回 日本高血圧学会総会, 10 Oct. 2008 - チアゾリジン（TZD）誘導体はキマーゼ依存性アンジオテンシンII産生系を抑制する。
上原吉就; 藤見幹太; 阿部智美; 三浦伸一郎; 岩本隆宏; 浦田秀則; 朔 啓二郎
第40回 日本動脈硬化学会総会, 11 Jul. 2008 - Low HDL-C: Role of lipid transporters and apoA-I mimetic peptides
第40回 日本動脈硬化学会総会, 11 Jul. 2008 - Reconstituted HDL Therapy for Cardiovascular Disease
Y.Uehara; SI.Miura; S.Imaizumi; Y.Kiya; M.Sata; Kerry-Anne Rye; K.Saku
The 77th European Atherosclerosis Society Congress, 29 Apr. 2008 - A Severity of Coronary Artery Disease is influenced by ATP-binding Cassette Transporter G1 (ABCG1) -257T>G Promoter Polymorphism.
Uehara Y; Furuyama S; Abe S; Okamura K; Miura S; Iwamoto T; Saku K
The 77th European Atherosclerosis Society Congress, 27 Apr. 2008 - A Severity of Coronary Artery Disease is influenced by ATP-binding Cassette Transporter G1 (ABCG1) -257T>G Promoter Polymorphism.
Uehara Y; Furuyama S; Abe S; Okamura K; Miura S; Iwamoto T; Saku K
The 77th European Atherosclerosis Society Congress, 27 Apr. 2008 - 本態性高血圧患者のメタボリック因子に対するARBテルミサルタンの効果
上原吉就; 三浦 伸一郎; 藤野正礼; 岩田 敦; 河村 彰; 朔 啓二郎
第104回 日本内科学会講演会, 11 Apr. 2008 - Effect of Pioglitazone on Lipid Profiles as Assessed by Analytical Capillary Isotachophoresis (cITP) in Patients with Type 2 Diabetes
Yoshinari Uehara; Bo Zhang; Akira Kawamura; Shin-ichiro Miura; Takahiro Iwamoto; Keijiro Saku
The 72st Annual Scientific Meeting of the Japanese Circulation Society, 29 Mar. 2008 - ATP-binding cassette transporter G4 (ABCG4) is highly expressed in Alzheimer brain
Y.Uehara; M.Higuchi; Y.Baba; T.Iwamoto; T.Yamada
The 25th International Psychogeriatric Association Congress, 17 Oct. 2007 - Reconstituted-HDL has a potential for anti-atherogenic lipoprotein modulator in patient with HDL deficiency
Yoshinari Uehara; Y. Kiya; B.Zhang; S.Abe; S.Miura; S.Furuyama; Kerry-Anne Rye; K.Saku
The 76th European Atherosclerosis Society Congress, 11 Jun. 2007 - Peroxisome Proliferator-Activated Receptorα Agonists Suppress a Fast-Migarating LDL by Capillary Isotachophoresis
Uehara Y; Zhang B; Furuyama S; Okamura K; Miura SI; Urata H; Yamada T; Saku K
The 71ｓｔ Annual Scientific Meeting of the Japanese Circulation Society, 16 Mar. 2007 - Reconstituted-HDL has a potential for anti-atherogenic lipoprotein modulator
Uehara Y; Zhang B; Abe S; Miura SI; Furuyama S; Yamada T; Saku K
The 71ｓｔ Annual Scientific Meeting of the Japanese Circulation Society, 16 Mar. 2007 - Angiotensin II forming-activities in the human mononuclear cell fraction isolated from the peripheral blood
S.Abe; Y.Inoue; Y.Tagomori; A.Ohtani; H.Ide; Y.Uehara; K.Saku; H.Urata
The 21st Scientific Meeting of the International Society of Hypertension, 19 Oct. 2006
- 骨格筋高比重リポ蛋白（HDL）産生システムの筋分化促進作用およびメカニズムの解明
日本学術振興会, 日本学術振興会 科学研究費基金 基盤研究（B）, 基盤研究(B)
福岡大学
Apr. 2024 - Mar. 2028 - 骨格筋量の維持に資するたんぱく質必要量と食習慣の解明
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B)
National Institutes of Biomedical Innovation, Health and Nutrition
01 Apr. 2023 - 31 Mar. 2027 - DNAメチル化を基盤とする運動適応機構の解明
日本学術振興会, 日本学術振興会 科学研究費補助金 基盤研究（B）, 基盤研究(B)
福岡大学
Apr. 2023 - Mar. 2027 - 非侵襲連続血圧計による心筋酸素消費量指標開発と最適な運動処方アルゴリズムの実用化
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
01 Apr. 2023 - 31 Mar. 2026 - 腎血流量を維持し腎臓にストレスをかけない最適な運動条件の探索
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
01 Apr. 2022 - 31 Mar. 2025 - 筋量増加に有効な食事処方に関する研究 ―糖質が筋タンパク質合成を促進する可能性―
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B)
Fukuoka University
01 Apr. 2022 - 31 Mar. 2025 - 「時間運動学」に基づいた疾病予防や改善のために有効な運動プログラムの開発
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B)
Fukuoka University
01 Apr. 2021 - 31 Mar. 2025 - 身体運動とうま味で奏でるスポーツと健康の価値の創造
日本学術振興会, 科学研究費助成事業, 挑戦的研究(開拓)
福岡大学
30 Jul. 2020 - 31 Mar. 2025 - 筋量増加に有効な食事処方に関する研究 ―糖質が筋タンパク質合成を促進する可能性―
日本学術振興会, 科学研究費助成事業, 基盤研究(B)
福岡大学
Apr. 2024 - Mar. 2025 - iPS 細胞由来の心筋・骨格筋細胞におけるアポリポ蛋白発現調節機構の解明とミトコンドリア機能への影響
国立大学法人 京都大学, 共同研究
Jan. 2019 - Dec. 2024 - 運動による骨格筋高比重リポ蛋白（HDL）産生システムの発動とその作用解明
基盤研究B
01 Apr. 2020 - 31 Mar. 2024 - エピジェネティック修飾によるによる運動適応による運動適応機構の解明
基盤研究B
01 Apr. 2019 - 31 Mar. 2023 - 除脂肪量増加に有効な食事処方に関する基礎的 研究
基盤研究B
01 Apr. 2019 - 31 Mar. 2023 - 新型（加熱式）タバコによる動脈硬化進展機構の解明
福岡大学研究推進部 領域別研究チーム
Apr. 2020 - Mar. 2023 - 不活動由来に増加してインスリン抵抗性を惹起する筋細胞内メッセンジャーの探索
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Challenging Research (Exploratory)
Fukuoka University
30 Jul. 2020 - 31 Mar. 2022 - 温熱とリカバリの関係解明に関する共同研究等
共同研究
29 Oct. 2020 - 31 Jul. 2021 - ウェアラブルデバイスを用いた運動強度評価に関 する研究
旭化成（株）, 共同研究
31 Mar. 2020 - 31 Mar. 2021 - 骨格筋の成長を促すアミノ酸や低分子ペプチドの探索と同定
挑戦的研究(萌芽)
29 Jun. 2018 - 31 Mar. 2020 - 運動によるHDL代謝・機能の向上作用とミトコンドリア機能へおよぼす効果の検討
基盤研究C
01 Apr. 2017 - 31 Mar. 2020 - 骨格筋糖取り込みを高める栄養・運動処方に関する基礎研究―ビタミンD に着目して―
基盤研究B
01 Apr. 2016 - 31 Mar. 2019 - エピジェネティック修飾を介する骨格筋糖代謝分子適応機構の解明
基盤研究B
01 Apr. 2015 - 31 Mar. 2019 - 健康寿命延伸と介護予防に寄与する運動 プロトコールの開発とシステム構築
基盤研究A
01 Apr. 2015 - 31 Mar. 2018 - HDL新生作用をもつ次世代型遺伝子導入ペプチドの開発と臨床応用
基盤研究C
01 Apr. 2013 - 31 Mar. 2016 - アルツハイマー病前駆段階の血清学的診断とビタミンＤによる進行阻止法の開発
基盤研究C
01 Apr. 2011 - 31 Mar. 2014 - 新規可溶性脂質輸送体を標的とした動脈硬化関連疾患の診断とその治療戦略
基盤研究C
01 Apr. 2010 - 31 Mar. 2013 - 細胞内コレステロール排出膜蛋白の作用機構解明とそれを標的とした血管病治療戦略
基盤研究C
01 Apr. 2007 - 31 Mar. 2010 - 糖尿病におけるABCA1遺伝子抑制メカニズムおよびそのプロモーター解析
若手研究B
01 Apr. 2004 - 31 Mar. 2006
- 特許第7493811号, JP2020016762, 生体情報測定装置、生体情報測定方法および生体情報測定プログラム
上原 吉就, 松田 拓朗, 田上 友季也 - US17/603,751, BIOLOGICAL INFORMATION MEASUREMENT DEVICE, BIOLOGICALINFORMATION METHOD, AND BIOLOGICAL INFORMATION MEASUREMENT PROGRAM.
- PCT国際出願(PCT/JP2020/016762), 生体情報測定装置、生体情報測定方法および生体情報測定プログラム
- 特願2019-078637, 運動強度測定装置、運動強度測定方法および運動強度測定プログラム
- 特許第6289937号, 特願2014-036549, リラキシンの製造方法
岩岡道男, 野口将人, 荒井堅太, 安東勢津子, 上原吉就 - 特許第5742029号, 特願2011-529947, コレステロール排出ペプチド
朔 啓二郎, 安東 勢津子, 上原 吉就
